Approved Formulations
LIST OF PRODUCT PERMISSION | |||
---|---|---|---|
S. No. | Product Name | Composition | Therapeutic Category |
1 | Acebrophylline Capsules 100 mg | Each capsule contains: Acebrophylline 100 mg Excipients q.s. Colour: Approved colour used | Anti-asthamatic ( Bronchodilator) |
2 | Aceclofenac Paracetamol and Chlorzoxazone Tablets | Each film coated tablet contains: Aceclofenac BP 100 mg Paracetamol BP 325 mg Chlorzoxazone USP 250mg Excipients q.s. Colours: Approved colours used | Anti-Inflammatory |
3 | Aceclofenac paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains: Aceclofenac BP 100 mg Paracetamol BP 325 mg Serratiopeptidase 15 mg (enteric coated granules eq. to enzyme activity 30,000 units) Excipients q.s. Colours: Approved colours used | Anti-Inflammatory |
4 | Aceclofenac & paracetamol Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Excipients q.s. Colours: Approved colours | Anti-Inflammatory |
5 | Aceclofenac and Drotaverine Hydrochloride Tablet | Each film coated tablet contains: Aceclofenac IP 100 mg Drotaverine Hydrochloride 80 mg Excipients: q.s. Colours: Approved Colours used | Anti-Inflammatory |
6 | Aceclofenac and Paracetamol Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Colours: Approved colour(s) | Anti-Inflammatory |
7 | Aceclofenac and Thiocolchicoside Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Thiocolchicoside IP 4 mg Excipents q.s. Colours: Approved colours | Anti-Inflammatory |
8 | Aceclofenac and Tizanidine Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Tizanidine Hydrochloride IP 2 mg Colours: Approved colours | Anti-Inflammatory +skeletal muscle relaxants |
9 | Aceclofenac Paracetamol and Chlorzoxazone Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg Colours: Approved colours | Anti-Inflammatory |
10 | Aceclofenac Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains Aceclofenac IP 100 mg Paracetamol IP 325 mg Serratiopeptidase IP 10 mg (Enteric coated granules eq. to enzyme activity 20,000 units) Excipients q.s. Colours: Approved colours | Anti-Inflammatory |
11 | Aceclofenac Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains Aceclofenac IP 100 mg Paracetamol IP 325 mg Serratiopeptidase IP 15 mg (Enteric coated granules eq. to enzyme activity 30,000 units) Excipients q.s. Colours: Approved colours | Anti-Inflammatory |
12 | Aceclofenac Sustained Release Tablets 200 mg | Each uncoated sustained release tablet contains: Aceclofenac IP 200 mg Excipients q.s. Colour: Approved colour used | Anti-Inflammatory |
13 | Aceclofenac Tablets IP 100 mg | Each film coated tablet contains: Aceclofenac IP 100 mg Excipients q.s. Colours: Approved colours | Anti-Inflammatory |
14 | Acetylcysteine and Ambroxol Hydrochloride Tablets | Each film coated tablet contains: Acetylcysteine BP 300 mg Ambroxol Hydrochloride IP 30 mg Excipients: q.s. Colour: Approved Colours | Anti-inflammatory |
15 | Albendazole & Ivermectin Chewable Tablets | Each uncoated chewable tablet contains: Albendazole IP 400 mg Ivermectin IP 6 mg Excipients: q.s. Colours: Approved colours | ANTI-BACTERIAL/ANTI-BIOTIC |
16 | Albendazole & Ivermectin Tablets | Each uncoated tablet contains: Albendazole IP 400 mg Ivermectin IP 6 mg Excipients q.s. Colours: Approved colours | ANTI-BACTERIAL/ANTI-BIOTIC |
17 | Albendazole Tablets IP | Each uncoated chewable tablet contains: Albendazole IP 400 mg Excipients: q.s. Colours: Approved colours | ANTI-BACTERIAL/ANTI-BIOTIC |
18 | Albendazole Tablets IP | Each uncoated chewable tablet contains: Albendazole IP 400 mg | ANTI-BACTERIAL/ANTI-BIOTIC |
19 | Amisulpride Tablets IP 200 mg | Each uncoated Tablet contains: Amisulpride IP 200mg Excipients q.s | Antipsychotic ( NEURO) |
20 | Amisulpride Tablets IP 50 mg | Each uncoated Tablet contains: Amisulpride IP 50mg Excipients q.s | Antipsychotic ( NEURO) |
21 | Amisulpride Tablets IP | Each uncoated tablet contains: Amisulpride IP 100 mg Excipients q.s. | Antipsychotic ( NEURO) |
22 | Amitryptyline Hydrochloride Tablets IP 10 mg | Each film coated tablet contains: Amitryptyline Hydrochloride IP 10 mg Excipients q.s Colour: Sunset Yellow FCF | Antidepressant ( Neuro) |
23 | Amitryptyline Hydrochloride Tablets IP 25 mg | Each film coated tablet contains: Amitryptyline Hydrochloride IP 25 mg Excipients q.s Colour: Sunset Yellow FCF | Antidepressant ( Neuro) |
24 | Amitryptyline Hydrochloride Tablets IP 50 mg | Each film coated tablet contains: Amitryptyline Hydrochloride IP 50 mg Excipients q.s Colour: Sunset Yellow FCF | Antidepressant ( Neuro) |
25 | Amlodipine Tablets IP | Each film coated tablet contains: Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. Colours: Approved colours | Anti-hypertensive ( Cardiac) |
26 | Amlodipine Tablets IP | Each uncoated tablet contains: Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. | Anti-hypertensive ( Cardiac) |
27 | Amlodipine Tablets IP 2.5 mg | Each uncoated tablet contains: Amlodipine Besylate IP Eq. to Amlodipine 2.5 mg Excipients q.s. | Anti-hypertensive ( Cardiac) |
28 | Aripiprazole Tablets IP 10 mg | Each uncoated Tablet contains: Aripiprazole IP 10 mg Excipients q.s Colour: Approved Colours | antipsychotic drug ( neuro) |
29 | Aripiprazole Tablets IP 15 mg | Each uncoated Tablet contains: Aripiprazole IP 15 mg Excipients q.s Colour: Approved Colours | antipsychotic drug ( neuro) |
30 | Aripiprazole Tablets IP 20 mg | Each uncoated Tablet contains: Aripiprazole IP 20 mg Excipients q.s Colour: Approved Colours | antipsychotic drug ( neuro) |
31 | Aripiprazole Tablets IP 30 mg | Each uncoated Tablet contains: Aripiprazole IP 30 mg Excipients q.s Colour: Approved Colours | antipsychotic drug ( neuro) |
32 | Aripiprazole Tablets IP 5 mg | Each uncoated Tablet contains: Aripiprazole IP 5 mg Excipients q.s Colour: Approved Colours | antipsychotic drug ( neuro) |
33 | Atenolol and Amlodipine Tablets | Each uncoated tablet contains: Atenolol IP 50 mg Amlodipine Besilate IP Eq. to Amlodipine 5 mg | Cardiac |
34 | Atorvastatin & Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg ( As immediate release pellets) Aspirin IP 75 mg ( As enteric coated pellets) Colour: Sunset Yellow FCF Approved colours used in empty capsule shells | anticholesteremic + nonsteroidal anti-inflammatory drug (NSAID) ( Cardiac) |
35 | Atorvastatin & Aspirin Capsules | Each hard gelatin capsule contains: Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg ( As immediate release pellets) Aspirin IP 75 mg ( As enteric coated pellets) Excipients q.s. Approved colours used in empty capsule shells | anticholesteremic + nonsteroidal anti-inflammatory drug (NSAID) ( Cardiac) |
36 | Atorvastatin & Clopidogrel Capsules | Each hard gelatin capsules contains: Atorvastatin calcium IP Eq. to Atorvastatin 10 mg ( As pellets) Colour: Approved colour Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg ( As pellets) Colour: Approved colour Approved colour used in empty capsule shells | anticholesteremic + Anti-platelet ( Cardiac) |
37 | Atorvastatin & Clopidogrel Capsules | Each hard gelatin capsules contains: Atorvastatin calcium IP Eq. to Atorvastatin 20 mg ( As pellets) Colour: Approved colour Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg ( As pellets) Colour: Approved colour Approved colour used in empty capsule shells | anticholesteremic + Anti-platelet ( Cardiac) |
38 | Atorvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg Fenofibrate(Micronized) IP 160 mg Colours: Approved Colours | anticholesteremic + antilipemic ( Cardiac) |
39 | Atorvastatin Calcium Tablets IP 10 mg | Each film coated tablets contains: Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg Excipients q.s. Colou: Approved colour(s) | anticholesteremic (Cardiac) |
40 | Atorvastatin Calcium Tablets IP 20 mg | Each film coated tablets contains: Atorvastatin Calcium IP Eq. to Atorvastatin 20 mg Excipients q.s. Colou: Approved colour(s) | anticholesteremic (Cardiac) |
41 | Atorvastatin Calcium Tablets IP 40 mg | Each film coated tablets contains: Atorvastatin Calcium IP Eq. to Atorvastatin 40 mg Excipients q.s. Colou: Approved colour(s) | anticholesteremic (Cardiac) |
42 | Atorvastatin Calcium Tablets USP | Each film coated tablets contains: Atorvastatin Calcium USP Eq. to Atorvastatin 10 mg Excipients q.s. Colou: Approved colours used | anticholesteremic (Cardiac) |
43 | Atorvastatin Calcium Tablets USP | Each film coated tablets contains: Atorvastatin Calcium USP Eq. to Atorvastatin 20 mg Excipients q.s. Colou: Approved colours used | anticholesteremic (Cardiac) |
44 | Azithromycin Tablets IP 250 mg | Each film coated tablet contains: Azithromycin Dihydrate IP Eq. tp Azithromycin 250 mg Excipients q.s. Colours: Approved colours | Antibacterial/anti-biotic |
45 | Azithromycin Tablets IP 500 mg | Each film coated tablet contains: Azithromycin Dihydrate IP Eq. tp Azithromycin 500 mg Excipients q.s. Colours: Approved colours | Antibacterial/anti-biotic |
46 | Azithromycin Tablets USP 250 mg | Each film coated tablet contains: Azithromycin Dihydrate USP Eq. tp Azithromycin 250 mg Excipients q.s. Colours: Approved colours used | Antibacterial/anti-biotic |
47 | Azithromycin Tablets USP 500 mg | Each film coated tablet contains: Azithromycin Dihydrate USP Eq. tp Azithromycin 500 mg Excipients q.s. Colours: Approved colours | Antibacterial/anti-biotic |
48 | Betahistine Dihydrochloride Tablets IP 16 mg | Each uncoated tablet contains: Betahistine Dihydrochloride IP 16 mg Excipients q.s. | ANTI-HISTAMINE |
49 | Betahistine Dihydrochloride Tablets IP 16 mg | Each film coated tablet contains: Betahistine Dihydrochloride IP 16 mg Excipients q.s. Colours: Approved colours | ANTI-HISTAMINE |
50 | Betahistine Dihydrochloride Tablets IP 8 mg | Each uncoated tablet contains: Betahistine Dihydrochloride IP 8 mg Excipients q.s. | ANTI-HISTAMINE |
51 | Betahistine Hydrochloride Tablets IP 16 mg | Each uncoated tablet contains: Betahistine Hydrochloride IP 16 mg Excipients q.s. | ANTI-HISTAMINE |
52 | Betahistine Hydrochloride Tablets IP 8 mg | Each uncoated tablet contains: Betahistine Hydrochloride IP 8 mg Excipients q.s. | ANTI-HISTAMINE |
53 | Betaistine Tablets IP 16 mg | Each uncoated tablet contains: Betahistine Hydrochloride IP 16 mg Excipients q.s. | ANTI-HISTAMINE |
54 | Betaistine Tablets IP 8 mg | Each uncoated tablet contains: Betahistine Hydrochloride IP 8 mg Excipients q.s. | ANTI-HISTAMINE |
55 | Calcium and Vitamin D3 Tablets IP | Each film coated tablets contains: 12.5 g of Calcium carbonate from an organic source ( Oyster Shell) Eq. to Elemental Calcium 500 mg Vitamin D3 IP 250 I.U. Overages of Vitamin added Colours: Approved colours | DIETARY SUPPLEMENT |
56 | Calcium Carbonate, Vitamin D3, Magnesium and Zinc tablets | Each film coated tablets contains: Calcium Carbonate IP 1250 mg Eq. to elemental Calcium 500 mg Vitamin D3 IP 250 I.U. Magnesium Hydroxide IP Eq. to Magnesium 100 mg Zinc Sulphate Monohydrate USP Eq. to Elemental Zinc 4 mg Overages of Vitamin added Colours: Approved colours | DIETARY SUPPLEMENT |
57 | Calcium Carbonate,Vitamin D3 Tablets | Each film coated tablets contains: 12.5 g of Calcium carbonate from an organic source ( Oyster Shell) Eq. to Elemental Calcium 500 mg Vitamin D3 IP 250 I.U. Overages of Vitamin added Colours: Approved colours | DIETARY SUPPLEMENT |
58 | Calcium Carbonate,Vitamin D3, Magnesium hydrochloride & Zinc Sulphate monohydrate Tablets | Each film coated tablet contains: Calcium carbonate IP 1250 mg Eq. to Element Calcium 500 mg Vitamin D3 IP 250 IU Magnesium Hydrochloride IP Eq. to Elemental magnesium 100 mg Zinc Sulphate monohydrate USP Eq. to Elemental Zinc 4 mg Colous: Approved colours | DIETARY SUPPLEMENT |
59 | Calcium CitrateMagnesium Hydrochloride Zinc Sulfate & vitamin D3 Tablets | Each uncoated tablet contains Calcium Citrate Maleate 500 mg Magnesium hydroxide IP Eq. to Elemental Magnesium 100 mg Zinc Sulfate monohydrate USP Eq. to Elemental Zinc 4 mg Vitamin D3 IP 200 IU Excipients q.s | DIETARY SUPPLEMENT |
60 | Carbamazepine controlled release Tablets IP 200 mg | Each uncoated controlled release tablet contains: Carbamazepine IP 200 mg | anticonvulsant drug ( Neuro) |
61 | Carbamazepine controlled release Tablets IP 300 mg | Each uncoated controlled release tablet contains: Carbamazapine IP 300 mg Colour: Iron Oxide Red & Iron Oxide yellow | anticonvulsant drug ( Neuro) |
62 | Carbamazepine Tablets IP 100 mg | Each uncoated Tablet contains: Carbamazepine IP 100mg Excipients q.s | anticonvulsant drug ( Neuro) |
63 | Carbamazepine Tablets IP 200 mg | Each uncoated Tablet contains: Carbamazepine IP 200mg Excipients q.s | anticonvulsant drug ( Neuro) |
64 | Carbamazepine Extended - Release Tablets USP 400 mg | Each uncoated extended - release tablet contains: Carbamazepine USP 400 mg Excipients q.s. | anticonvulsant drug ( Neuro) |
65 | Cetirizine Hydrochloride Tablets IP 10 mg | Each uncoated tablet contains: Cetirizine Hydrochloride IP 10mg Excipients q.s. | ANTI-HISTAMINE |
66 | Cilinidipine Tablets IP 10 mg | Each film coated tablet contains: Cilnidipine IP 10 mg Excipients q.s | Anti-hypertensive ( Cardiac) |
67 | Cilinidipine Tablets IP 5 mg | Each film coated tablets contains: Cilindipine IP 5 mg Excipients: q.s Colours: Approved colours | Anti-hypertensive ( Cardiac) |
68 | Ciprofloxacin and Ornidazole Tablets | Each film coated tablet contains: Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 500 mg Ornidazole IP 500 mg Colours: Approved Colours | ANTI-BACTERIAL/ANTI-BIOTIC |
69 | Ciprofloxacin Tablets IP 250 mg | Each film coated tablet contains: Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 250 mg Excipients q.s. Colours: Approved Colour(s) | ANTI-BACTERIAL/ANTI-BIOTIC |
70 | Ciprofloxacin Tablets IP 500 mg | Each film coated tablet contains: Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 500 mg Excipients q.s. Colours: Approved Colour(s) | ANTI-BACTERIAL/ANTI-BIOTIC |
71 | Ciprofloxacin Tablets USP 250 mg | Each film coated tablet contains: Ciprofloxacin Hydrochloride USP Eq. to Ciprofloxacin 250 mg Excipients q.s. Colours: Approved Colour used | ANTI-BACTERIAL/ANTI-BIOTIC |
72 | Ciprofloxacin Tablets USP 500 mg | Each film coated tablet contains: Ciprofloxacin Hydrochloride USP Eq. to Ciprofloxacin 500 mg Excipients q.s. Colours: Approved Colour used | ANTI-BACTERIAL/ANTI-BIOTIC |
73 | Ciprofloxacin Tablets USP 500 mg | Each film coated tablet contains: Ciprofloxacin Hydrochloride USP Eq. to Ciprofloxacin 500 mg Excipients q.s. Colours: Approved Colours used | ANTI-BACTERIAL/ANTI-BIOTIC |
74 | Clindamycin capsules IP | Each hard gelatin capsule contains: Clindamycin Hydrochloride IP Eq. to Clindamycin 300 mg Excipients q.s. Approved colours used in empty hard gelatin capsule shells | ANTI-BACTERIAL/ANTI-BIOTIC |
75 | Clopidogrel Tablets IP 75 mg | Each film coated tablet contains: Clopidogrel Bisulfate IP Eq. to Clopidogrel 75 mg Excipients q.s. Colours: Approved colours | antiplatelet ( Cardiac) |
76 | Clopidogrel Tablets USP 75 mg | Each film coated tablet contains: Clopidogrel Bisulfate USP Eq. to Clopidogrel 75 mg Excipients q.s. Colours: Approved colours | antiplatelet ( Cardiac) |
77 | Clozapine Tablets IP 100 mg | Each uncoated tablet contains: Clozapine IP 100 mg | atypical antipsychotics ( NEURO) |
78 | Clozapine Tablets IP 25 mg | Each uncoated tablet contains: Clozapine IP 25 mg | atypical antipsychotics ( NEURO) |
79 | Clozapine Tablets IP 50 mg | Each uncoated tablet contains: Clozapine IP 50 mg | atypical antipsychotics ( NEURO) |
80 | Deflazacort Tablets 6 mg | Each uncoated tablet contains: Deflazacort 6mg Excipients q.s. | ANTI INFLAMMATORY |
81 | Diacerein Capsules IP 50 mg | Each hard gelatin capsule contains: Diaerein IP 50 mg Excipients q.s. Approved coloursused in empty hard gelatin capsules shells | ANTI INFLAMMATORY |
82 | Diacerein, Glocosamine Sulphate Tablets | Each film coated tablet contains: Glucosamine Sulphate Potassium Chloride USP 500 mg Eq. to Glucosamine 296mg Diaerein IP 50 mg Excipients q.s. Colours: Approved colour | ANTI INFLAMMATORY |
83 | Diclofenac and Thiocolchicoside Capsules | Each hard gelatin capsule contains: Diclofenac Sodium BP 50 mg Thiocolchicoside IP 8 mg Approved colours used in empty hard gelatin capsule shells | ANTI INFLAMMATORY |
84 | Diclofenac Potassium & Paracetamol Tablets | Each uncoated tablet contains: Diclofenac Potassium BP 50 mg Paracetamol IP 325 mg Excipients: q.s. | ANTI INFLAMMATORY |
85 | Diclofenac Potassium & Serratiopeptidase Tablets | Each enteric coated tablet contains: Diclofenac Potassium BP 50 mg Serratiopeptidase IP 10 mg (Enteric coated granules eq. to enzyme activity 20,000units) Excipients: q.s. Colours: Approved colours | ANTI INFLAMMATORY |
86 | Diclofenac Potassium, Magnesium trisilicate, Chlorpheniramine maleate & Paracetamol Tablets | Each uncoated tablet contains: Diclofenac Potassium BP 50 mg Paracetamol IP 325 mg Magnesium trisilicate IP 100 mg Chlorpheniramine maleate IP 4 mg Excipients q.s. | Anti-Infammatory + Anti-histamine |
87 | Diclofenac Prolonged Release Tablets IP 100 mg | Each prolonged release tablet contains: Diclofenac sodium IP 100 mg Excipients q.s. Colours: Approved colours | ANTI INFLAMMATORY |
88 | Diclofenac sodium & Serratiopeptidse Tablets | Each film coated tablet contains: Diclofenac sodium IP 50 mg Serratiopeptidase IP 10 mg ( enteric coated granules Eq. to enyme activity 20,000 units) Excipients q.s. Colours: Approved colours | ANTI INFLAMMATORY |
89 | Diclofenac sodium & Serratiopeptidse Tablets | Each enteric coated tablet contains: Diclofenac sodium IP 50 mg Serratiopeptidase IP 10 mg ( As enteric coated granules Equivalent to enyme activity 20,000 units) Excipients q.s. Colours: Approved colour(s) | ANTI INFLAMMATORY |
90 | Diclofenac Sodium and Paracetamol Tablets IP | Each uncoated tablet contains: Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Excipients q.s. | ANTI INFLAMMATORY |
91 | Diclofenac Sodium Tablets IP 50 mg | Each film coated tablet contains: Diclofenac sodium IP 50 mg Excipients q.s. Colours: Approved colours | ANTI INFLAMMATORY |
92 | Diclofenac Sodium Tablets IP 50 mg | Each enteric coated tablet contains: Diclofenac Sodium IP 50 mg Excipients q.s. Colours: Approved colours | ANTI INFLAMMATORY |
93 | Diclofenac Sodium,Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains: Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Serratiopeptidase IP 15 mg (Enteric coated granule eq. to enzyme activity 30,000 units) Excipients q.s. Colours: Approved colour(s) | ANTI INFLAMMATORY |
94 | Disulfirm Tablets IP 250 mg | Each uncoated Tablet contains: Disulfirm IP 250mg Excipients q.s | Anti-alcoholism ( Neuro) |
95 | Divalproex sodium Extended - release Tablets IP 250 mg | Each film coated extended release tablet contains: Divalprox sodium IP Eq. to Valproic acid 250 mg Colour: Approved colours | anti-epileptics ( neuro) |
96 | Divalproex sodium Extended - release Tablets IP 500 mg | Each film coated extended release tablet contains: Divalprox sodium IP Eq. to Valproic acid 500 mg Colour: Approved colours | anti-epileptics ( neuro) |
97 | Divalproex sodium Extended - release Tablets IP 750 mg | Each film coated extended release tablet contains: Divalprox sodium IP Eq. to Valproic acid 750 mg Excipients: q.s. Colour: Approved colours | anti-epileptics ( neuro) |
98 | Divalproex sodium Gastro-Resistant Tablets IP 500 mg | Each enteric coated tablet contains: Divalprox sodium IP Eq. to Valproic acid 500 mg Colour: Approved colours | anti-epileptics ( neuro) |
99 | Divalproex Sodium Prolonged - release Tablets IP 250 mg | Each film coated prolonged release tablet contains: Divalproex sodium IP Eq. to Valproic acid 250 mg Excipients q.s. Colours : Approved colours | anti-epileptics ( neuro) |
100 | Divalproex Sodium Prolonged - release Tablets IP 500 mg | Each film coated prolonged release tablet contains: Divalproex sodium IP Eq. to Valproic acid 500 mg Excipients q.s. Colours : Approved colours | anti-epileptics ( neuro) |
101 | Divalproex sodium prolonged-release Tablets IP 1000 mg | Each film coated prolonged release Tablet contains: Divalproex sodium IP Eq. to Valporic acid 1000 mg Excipients q.s Colour: Approved Colours | anti-epileptics ( neuro) |
102 | Divalproex sodium prolonged-release Tablets IP 125 mg | Each film coated prolonged release Tablet contains: Divalproex sodium IP Eq. to Valporic acid 125 mg Excipients q.s Colour: Approved Colours | anti-epileptics ( neuro) |
103 | Divalproex sodium prolonged-release Tablets IP 750 mg | Each film coated prolonged release Tablet contains: Divalproex sodium IP Eq. to Valporic acid 750 mg Excipients q.s Colour: Approved Colours | anti-epileptics ( neuro) |
104 | Domperidone Tablets IP | Each uncoated tablets contains: Domperidone Maleate IP Eq. to Domperidone 10 mg Excipients q.s. Colours: Approved colours | Gastro-Resistant |
105 | Dothiepin Hydrochloride Tablets IP 25 mg | Each film coated Tablet Contains: Dothiepin Hydrochloride IP 25 mg Excipients q.s Colour: Approved Colours | Anti-depressant ( Neuro) |
106 | Dothiepin Hydrochloride Tablets IP 50 mg | Each film coated Tablet Contains: Dothiepin Hydrochloride IP 50 mg Excipients q.s Colour: Approved Colours | Anti-depressant ( Neuro) |
107 | Dothiepin Hydrochloride Tablets IP 75 mg | Each film coated Tablet Contains: Dothiepin Hydrochloride IP 75 mg Excipients q.s Colour: Approved Colours | Anti-depressant ( Neuro) |
108 | Doxofylline Tablets IP 400 mg | Each uncoated tablet contains: Doxofylline IP 400 mg Excipients q.s. | Anti-asthamatic ( Bronchodilator) |
109 | Doxylamine Succinate, Pyridoxine hydrochloride & Folic scid Tablets | Each enteric coated tablet contains: Doxylamine Succinate USP 10 mg Pyridoxine hydrochloride IP 4 mg Folic acid IP 2.5 mg Colours: Approved colours | Antihistamine + Dietary Supplement |
110 | Drotaverine and Aceclofenac Tablet | Each film coated tablet contains: Drotaverine 80 mg Aceclofenac Ip 100 mg Colours: Approved Colours | ANTI INFLAMMATORY |
111 | Drotaverine Hydrochloride and Mefenamic Acid Tablets | Each film coated tablet contains: Drotaverine Hydrochloride 80 mg Mefenamic Acid IP 250 mg Excipients q.s. Colours: Approved colours | ANTI INFLAMMATORY |
112 | Duloxetine Gastro resistant Tablets IP 20 mg | Each enteric coated tablet contains: Duloxetine Hydrochloride IP Eq. to Duloxetine 20 mg Excipients: q.s Colout : Approved Colour(s) | SSNRI ( neuro) |
113 | Duloxetine Gastro resistant Tablets IP 40 mg | Each enteric coated tablet contains: Duloxetine Hydrochloride IP Eq. to Duloxetine 40 mg Excipients: q.s Colout : Sunset Yellow | SSNRI ( neuro) |
114 | Duloxetine Gastro resistant Tablets IP 60 mg | Each enteric coated tablet contains: Duloxetine Hydrochloride IP Eq. to Duloxetine 60 mg Excipients: q.s Colout : Approved Colour | SSNRI ( neuro) |
115 | Enteric coated Esomeprazole Magnesium & Domperidone Sustained release Capsules | Each hard gelatin capsule contains: Esomeprazole Magnesium Trihydrate IP Eq. to Esomeprazole 20 mg ( as enteric coated pellets) Colour: Yellow Oxide of Iron Domperidone IP 30 mg ( As sustained release pellets) Colour: Sunset release FCF Approved colours used in empty hard gelatin capsule shells | Gastro-Resistant |
116 | Enteric coated Esomeprazole Magnesium & Domperidone Sustained release Capsules | Each hard gelatin capsule contains: Esomperazole Magnesium Trihydrate IP Eq. to Esomeprazole 20 mg ( As enteric coated pellets) Colour: Yellow Oxide of Iron Domperidone IP 30 mg ( As sustained release pellets) Colour: Sunset Yellow FCF Approved colours used in hard gelatin capsule shells | Gastro-Resistant |
117 | Enteric coated Esomeprazole Magnesium & Domperidone Sustained release Capsules | Each hard gelatin capsule contains: Esomperazole Magnesium Trihydrate IP Eq. to Esomeprazole 40 mg ( As enteric coated pellets) Colour: Yellow Oxide of Iron Domperidone IP 30 mg ( As sustained release pellets) Colour: Sunset Yellow FCF Approved colours used in hard gelatin capsule shells | |
118 | Escitalopram Oxalate Tablets IP 10 mg | Each film coated Tablet Contains: Escitalopram Oxalate IP Eq. to Escitalopram 10 mg Excipients q.s Colour: Approved Colours | Antidepressant ( Neuro) |
119 | Escitalopram Oxalate Tablets IP 20 mg | Each film coated Tablet Contains: Escitalopram Oxalate IP Eq. to Escitalopram 20 mg Excipients q.s Colour: Approved Colours | Antidepressant ( Neuro) |
120 | Escitalopram Oxalate Tablets IP 5 mg | Each film coated Tablet Contains: Escitalopram Oxalate IP Eq. to Escitalopram 5 mg Excipients q.s Colour: Approved Colours | Antidepressant ( Neuro) |
121 | Escitalopram Tablets USP | Each film coated tabet contains: Escitalopram oxalate USP Eq. to Escitalopram 10 mg Excipients q.s. Colours: Approved colours used | Antidepressant ( Neuro) |
122 | Esomeprazole ( EC) & Domperidone ( SR) Capsules | Each hard gelatin capsule contains: Esomperazole Magnesium Trihydrate IP Eq. to Esomeprazole 40 mg ( As enteric coated pellets) Domperidone Maleate IP Eq. to Domperidone 30 mg ( As sustained release pellets) Approved colours used in hard gelatin capsule shells | Gastro-Resistant |
123 | Esomeprazole ( EC) & Domperidone ( SR) Capsules | Each hard gelatin capsule contains: Esomperazole Magnesium Trihydrate IP Eq. to Esomeprazole 40 mg ( As enteric coated pellets) Colour: Titanium Dioxide IP Domperidone IP 30 mg ( As sustained release pellets) Colour: Sunset Yelow FCF Approved colours used in hard gelatin capsule shells | Gastro-Resistant |
124 | Esomeprazole Gastro- resistant Tablets IP 20 mg | Each enteric coated tablet contains: Esomeprazole Magnesium Trihydrate IP Eq. to Esomeprazole 20 mg Excipients q.s. Colour: Approved colour(s) | |
125 | Esomeprazole Gastro- resistant Tablets IP 40 mg | Each enteric coated tablet contains: Esomeprazole Magnesium Trihydrate IP Eq. to Esomeprazole 40 mg Excipients q.s. Colour: Approved colour(s) | Gastro-Resistant |
126 | Esomeprazole Gastro- resistant Tablets IP 40 mg ULCELIX | Each enteric coated tablet contains: Esomeprazole Magnesium Trihydrate USP Eq. to Esomeprazole 40 mg Excipients q.s. Colour: Approved colours used | Gastro-Resistant |
127 | Etodolac & Thiocolchicoside Tablets | Each film coated tablet contains: Etodolac IP 400 mg Thiocolchicoside Ip 4 mg Excipients q.s. Colours: ferric Oxide Yellow USP - NF & Titanium Dioxide IP | Anti- Inflammatory |
128 | Etoricoxib Tablets IP 60 mg | Each film coated tablet contains: Etoricoxib IP 60 mg Excipients q.s. Colour: Titanium Dioxide IP | NSAID ( Anti-inflammatory) |
129 | Etoricoxib Tablets IP 90 mg | Each film coated tablet contains: Etoricoxib IP 90 mg Excipients q.s. Colour: Approved colour used | NSAID ( Anti-inflammatory) |
130 | Febuxotat Tablets 40 mg | Eah film coated tablet contains: Febuxoat 40 mg Excipients q.s. Colours: Approved colours | antihyperuricemic |
131 | Ferrous Ascorbate, Folic acid and Zinc Sulphate Tablets | Each film coated tablet contains: Ferrous Ascorbate IP Eq. to Elemental Iron 100 mg Folic Acid IP 1.5 mg Zinc Sulphate Monohydrate IP Eq. to Elemental Zinc 22.5 mg Excipients q.s. Colour: Approved colour(s) | DIETARY SUPPLEMENT |
132 | Ferrous Ascorbate, Folic acid and Zinc Sulphate Tablets | Each film coated tablet contains: Ferrous Ascorbate IP 190 mg Folic Acid IP 1.5 mg Zinc Sulphate Monohydrate IP 22.5 mg Excipients q.s. Colour: Approved colour(s) | DIETARY SUPPLEMENT |
133 | Fexofenadine Hydrochloride 120 mg and Montelukast Sodium 10 mg tablets | Each uncoated bilayered tablet contains: Fexofenadine Hydrochloride IP 120 mg Montelukast Sodium IP Eq. to Montelukast 10 mg Excipients q.s. Colour: Yellow oxide of Iron | ANTI-HISTAMINE |
134 | Fexofenadine Hydrochloride Tablets IP 120 mg | Each film coated tablet contains: Fexofenadine Hydrochloride IP 120 mg Excipients q.s. Colours: Yellow oxide Iron Red Oxide Iron & Titanium dioxide IP | ANTI-HISTAMINE |
135 | Fexofenadine hydrochloride Tablets IP 120 mg | Each film coated tablet contains: Fexofenadine Hydrochloride IP 120 mg Excipients q.s. Colours: Approved colours | ANTI-HISTAMINE |
136 | Fexofenadine Hydrochloride Tablets IP 120 mg | Each film coated tablet contains: Fexofenadine Hydrochloride IP 120 mg Excipients q.s. Colours: Ferric Oxide Yellow USP NF, Ferric Oxide Red USP NF & Titanium dioxide IP | ANTI-HISTAMINE |
137 | Fexofenadine Hydrochloride Tablets IP 180 mg | Each film coated tablet contains: Fexofenadine Hydrochloride IP 180 mg Excipients q.s. Colours: Yellow oxide Iron Red Oxide Iron & Titanium dioxide IP | ANTI-HISTAMINE |
138 | Fexofenadine hydrochloride Tablets IP 180 mg | Each film coated tablet contains: Fexofenadine Hydrochloride IP 180 mg Excipients q.s. Colours: Approved colours | ANTI-HISTAMINE |
139 | Fexofenadine Hydrochloride Tablets IP 180 mg | Each film coated tablet contains: Fexofenadine Hydrochloride IP 180 mg Excipients q.s. Colours: Ferric Oxide Yellow USP NF, Ferric Oxide Red USP NF & Titanium dioxide IP | ANTI-HISTAMINE |
140 | Fluconazole Tablets IP 150 mg | Each tablet contains: Fluconazole IP 150 mg Excipients q.s. Colours: Approved colours used | ANTI-BACTERIAL/ANTI-BIOTIC |
141 | Fluconazole Tablets USP 150 mg | Each tablet contains: Fluconazole USP 150 mg Excipients q.s. Colours: Approved colours used | ANTI-BACTERIAL/ANTI-BIOTIC |
142 | Flunarizine Dihydrochloride Tablets IP 10 mg | Each uncoated Tablet contains: Flunarizine Dihydrochloride IP Eq. to Flunarizine 10 mg Colour: Sunset Yellow | Neuro |
143 | Flunarizine Dihydrochloride Tablets IP 5 mg | Each uncoated Tablet contains: Flunarizine Dihydrochloride IP Eq. to Flunarizine 5 mg Colour: Sunset Yellow | Neuro |
144 | Fluoxetine Hydrochloride Capsule IP 10 mg | Each hard gelatin capsule contains: Fluoxetine Hydrochloride IP Equivalent to Fluoxetine 10 mg Approved Colour used in capsule shells | SSNRI ( neuro) |
145 | Fluoxetine Hydrochloride Capsule IP 20 mg | Each hard gelatin capsule contains: Fluoxetine Hydrochloride IP Equivalent to Fluoxetine 20 mg Approved Colour used in capsule shells | SSNRI ( neuro) |
146 | Fluoxetine Hydrochloride Tablets IP 10 mg | Each film coated Tablet Contains: Fluoxetine Hydrochloride IP Eq. to Fluoxetine 10 mg Excipients q.s Colour: Approved Colours | SSNRI ( neuro) |
147 | Fluoxetine Hydrochloride Tablets IP 20 mg | Each film coated Tablet Contains: Fluoxetine Hydrochloride IP Eq. to Fluoxetine 20 mg Excipients q.s Colour: Approved Colours | SSNRI ( neuro) |
148 | Fluoxetine Hydrochloride Tablets IP 40 mg | Each film coated Tablet Contains: Fluoxetine Hydrochloride IP Eq. to Fluoxetine 40 mg Excipients q.s Colour: Approved Colours | SSNRI ( neuro) |
149 | Flupenthixol and Melitracen Tablets | Each film coated tablet contains: Flupenthixol Hydrochloride BP Eq. to Flupenthixol 0.5 mg Melitracen Hydrochloride Eq. to Melitracen 10 mg Excipients q.s. Colour: Approved colour(S) | Anipsychotic ( Neuro) |
150 | Gabapentin and Methylcobalamin Tablets | Each film coated tablet contains: Gabapentin IP 300 mg Methylcobalamin IP 500 mcg Excipients q.s. Colour: Approved colour(s) | anticonvulsants + Dietary Supplement ( Neuro) |
151 | Gabapentin Capsules IP 100mg | Each hard gelatin capsulecontains: Gabapentin IP 100 mg Excipients q.s. Approved colours used in empty gelatin capsule shells | Anticonvulsant ( Neuro) |
152 | Gabapentin Tablets IP 100mg | Each film coated tablet contains: Gabapentin IP 100 mg Colour: Approved colours | Anticonvulsant ( Neuro) |
153 | Gabapentin Tablets IP 300 mg | Each film coated Tablet Contains: Gabapentin IP 300 mg Excipients q.s Colour: Approved Colours | Anticonvulsant ( Neuro) |
154 | Gliclazide & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Gliclazide IP 80 mg Metformin hydrochloride IP 500 mg Excipients q.s. Colour: Tartrazine | Anti-diabetic |
155 | Gliclazide & Metforminhydrochloride Tablets | Each uncoated tablet contains: Gliclazide IP 80 mg Metformin hydrochloride IP 500 mg Excipients q.s | Anti-diabetic |
156 | Gliclazide Modified Release Tablets 30 mg | Each uncoated modified release tablet contains: Gliclazide IP 30 mg Excipients q.s. | Anti-diabetic |
157 | Gliclazide Modified Release Tablets 30 mg | Each uncoated modificed release tablet contains: Gliclazide BP 30 mg Excipients q.s. | Anti-diabetic |
158 | Gliclazide Modified Release Tablets 60 mg | Each uncoated modified release tablet contains: Gliclazide IP 60 mg Excipients q.s. | Anti-diabetic |
159 | Gliclazide Modified Release Tablets 60 mg | Each uncoated modificed release tablet contains: Gliclazide BP 60 mg Excipients q.s. | Anti-diabetic |
160 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg Excipients q.s Colours: Approved colours | Anti-diabetic |
161 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg Excipients: q.s. Colours: Approved colours | Anti-diabetic |
162 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg ( In sustained release form) Excipients: q.s. Colours: Approved colours | Anti-diabetic |
163 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg ( In sustained release form) Excipients: q.s. Colours: Approved colours | Anti-diabetic |
164 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 1000 mg ( In sustained release form) Excipients q.s Colours: Approved colours | Anti-diabetic |
165 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 2 mg Metformin Hydrochloride IP 1000 mg ( In sustained release form) Excipients q.s Colours: Approved colours | Anti-diabetic |
166 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg Excipients q.s | Anti-diabetic |
167 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg Excipients q.s | Anti-diabetic |
168 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg Excipients q.s. | Anti-diabetic |
169 | Glimepiride & Metformin Hydrochloride Tablets | Each uncoated tablet contains: Glimepiride IP 1 mg Metformin Hydrochloride IP 500 mg Excipients q.s. | Anti-diabetic |
170 | Glimepiride Tablets IP 1 mg | Each uncoated tablet contains: Glimepiride IP 1 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
171 | Glimepiride Tablets IP 2 mg | Each uncoated tablet contains: Glimepiride IP 2 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
172 | Glimepiride Tablets IP 3 mg | Each uncoated tablet contains: Glimepiride IP 3 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
173 | Glimepiride Tablets IP 4 mg | Each uncoated tablet contains: Glimepiride IP 4 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
174 | Glimepiride, Pioglitazone HCl & Metformin Hydrochloride ( SR) Tablets | Each uncoated bilayered tablet contains: Glimepiride IP 2 mg Pioglitazone Hydrohloride IP Eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg ( In prolonged release form) Excipients q.s. Colours: Approved colours | Anti-diabetic |
175 | Glipizide & Metformin Hydrochloride Tablets IP | Each uncoated tablet contains: Glipizide IP 5 mg Metformin Hydrochloride IP 500 mg Excipients q.s. | Anti-diabetic |
176 | Glucosamine Sulphate & Chondroitin Sulphate Tablets | Eah film coated tablet contains: Glucosamine Sulphate 500 mg ( added as glucosamine Sulphate sodium chloride) Chondroitin Sulphate sodium 400 mg ( added as Chondroitin Sulphate Sodium) Colours: approved colours | Anti-inflammatory + Dietary supplement |
177 | Glucosamine sulphate , Methyl Sulfonyl Methane & Diacerein Tablets | Each film coated tablet contains: Glucosamine Sulphate Potassium Chloride USP 750 mg Methyl Sulfonyl Methane USP 250 mg Diacerein IP 50 mg Excipients: q.s. Colours: Approved colours | Anti-inflammatory |
178 | Glucosamine Tablets USP | Each film coated tablet contains: Glucosamine Sulphate Potassium chloride USP 500 mg Eq. to Glucosamine 296 mg Ecipients: q.s. Colours: Approved colours | DIETARY SUPPLEMENT |
179 | Haloperidol Tablets IP 0.25 mg | Each uncoated Tablet Contains: Haloperidol IP 0.25 mg Colour: Approved Colours | Antipsychotic ( Neuro) |
180 | Haloperidol Tablets IP 1.5 mg | Each uncoated Tablet Contains: Haloperidol IP 1.5 mg Colour: Approved Colours | Antipsychotic ( Neuro) |
181 | Haloperidol Tablets IP 10 mg | Each uncoated Tablet Contains: Haloperidol IP 10 mg Colour: Approved Colours | Antipsychotic ( Neuro) |
182 | Haloperidol Tablets IP 20 mg | Each uncoated Tablet Contains: Haloperidol IP 20 mg Colour: Approved Colours | Antipsychotic ( Neuro) |
183 | Haloperidol Tablets IP 5 mg | Each uncoated Tablet Contains: Haloperidol IP 5 mg Colour: Approved Colours | Antipsychotic ( Neuro) |
184 | Hydroxyzine Hydrochloride Tablets IP 10 mg | Each film coated tablet contains: Hydroxyzine Hydrohloride IP 10 mg Excipients q.s. Colours: Approved colour(s) | antihistamines |
185 | Hydroxyzine Hydrochloride Tablets IP 25 mg | Each film coated tablet contains: Hydroxyzine Hydrohloride IP 25 mg Excipients q.s. Colours: Approved colour(s) | antihistamines |
186 | Hyocine Butylbromide and Paracetamol Tablets | Each film coated tablet contains: Hyoscine Butylbromide IP 10 mg Paracetamol IP 325 mg Excipients q.s. Colour: Titanium dioxide IP | Antiinflammatory |
187 | Ibuprofen and Paracetamol Tablets | Each uncoated tablet contains: Ibuprofen IP 400 mg Paracetamol IP 325 mg Excipients q.s. | NSAID ( Anti-inflammatory) |
188 | Itraconazole Capsules 100 mg | Each hard gelatin capsule contains: Itraconazole USP 100 mg ( As pellets) Approved colours used in empty hard gelatin capsule shells | ANTI-BACTERIAL/ANTI-BIOTIC |
189 | Itraconazole Capsules 50 mg | Each hard gelatin capsule contains: Itraconazole IP 50 mg ( As pellets) Approved colours used in empty hard gelatin capsule shells | ANTI-BACTERIAL/ANTI-BIOTIC |
190 | Ivermectin Tablets IP 12 mg | Each uncoated tablet contains: Ivermectin IP 12 mg Excipients q.s. | ANTI-BACTERIAL/ANTI-BIOTIC |
191 | Ivermectin Tablets IP 6 mg | Each uncoated tablet contains: Ivermectin IP 6mg Excipients q.s. | ANTI-BACTERIAL/ANTI-BIOTIC |
192 | Lactilol Monohydrate and Ispaghula Husk Granules | Each 15 g of granules contains: Lactilol Monohydrate USP 10 g Ispaghula Husk IP 3.5 g Excipients q.s. Colour: Approved colour | LAXATIVE |
193 | Lactulose and Ispaghula Husk Granules | Each 20 g of granules contains: Lactulose Concentrate USP Eq. to Lactulose 10 g Ispaghula Husk 3.5 g Colour: Approved colours | LAXATIVE |
194 | Lamotrigine modified release Tablets 50 mg | Each uncoated modified released tablet contains: Lamotrigine IP 50 mg Excipients q.s Colour: Approved Colours | Neuro |
195 | Levetiracetam Tablets IP 1000 mg | Each uncoated tablet contains: Levetiracetam IP 1000 mg Excipients q.s. | anticonvulsant( Neuro) |
196 | Levetiracetam Tablets IP 250 mg | Each uncoated tablet contains: Levetiracetam IP 250 mg Excipients q.s. | anticonvulsant( Neuro) |
197 | Levetiracetam Tablets IP 250 mg | Each film coated tablet contains: Levetiracetam IP 250 mg Excipients q.s. Colours: Approved colours | anticonvulsant( Neuro) |
198 | Levetiracetam Tablets IP 500 mg | Each uncoated tablet contains: Levetiracetam IP 500 mg Excipients q.s. | anticonvulsant( Neuro) |
199 | Levetiracetam Tablets IP 500 mg | Each film coated tablet contains: Levetiracetam IP 500 mg Excipients q.s. Colours: Approved colours | anticonvulsant( Neuro) |
200 | Levetiracetam Tablets IP 750 mg | Each uncoated tablet contains: Levetiracetam IP 750 mg Excipients q.s. | anticonvulsant( Neuro) |
201 | Levetiracetam Tablets USP 500 mg | Each film coated tablet contains: Levetiracetam USP 150 mg Excipients q.s. Colours: Approved colours used | anticonvulsant( Neuro) |
202 | Levocetirizine Dihydrochloride Tablets IP | Each uncoated tablet contains: Levocetirizine Dihydrochloride IP 5 mg Excipients q.s. | antihistamines |
203 | Levocetirizine Dihydrochloride Tablets IP | Each film coated tablet contains: Levocetirizine Dihydrochloride IP 10 mg Excipients q.s. Colours: Approved Colour(s) | antihistamines |
204 | Levocetirizine Tablets IP 5 mg | Each film coated tablet contains: Levocetirizine Hydrochloride IP 5 mg Excipients q.s. Colours: Approved Colours | antihistamines |
205 | Levofloxacin and Ornidazole Tablets | Each film coated tablet contains: Levofloxacin Hemihydrate IP Eq. to Levofloxacin 250 mg Ornidazole IP 500 mg Excipients q.s. Colours: Approved Colours | ANTI-BACTERIAL/ANTI-BIOTIC |
206 | Levofloxacin Tablets IP 250 mg | Each film coated tablet contains: Levofloxacin Hemihydrate IP Eq. to levofloxacin 250 mg Excipients q.s. Colours: Approved Colours | ANTI-BACTERIAL/ANTI-BIOTIC |
207 | Levofloxacin Tablets IP 500 mg | Each film coated tablet contains: Levofloxacin Hemihydrate IP Eq. to levofloxacin 500 mg Excipients q.s. Colours: Approved Colours | ANTI-BACTERIAL/ANTI-BIOTIC |
208 | Levofloxacin Tablets USP 250 mg | Each film coated tablet contains: Levofloxacin Hemihydrate USP Eq. to Levofloxacin 250 mg Excipients q.s. Colours: Approved Colours used | ANTI-BACTERIAL/ANTI-BIOTIC |
209 | Levofloxacin Tablets USP 500 mg | Each film coated tablet contains: Levofloxacin Hemihydrate USP Eq. to Levofloxacin 500 mg Excipients q.s. Colours: Approved Colours used | ANTI-BACTERIAL/ANTI-BIOTIC |
210 | Levofloxacin Tablets USP 750 mg | Each film coated tablet contains: Levofloxacin Hemihydrate USP Eq. to Levofloxacin 750 mg Excipients q.s. Colours: Approved Colours used | ANTI-BACTERIAL/ANTI-BIOTIC |
211 | Levosulpiride Tablets | Each film coated tablet contains: Levosulpiride 25 mg Excipients q.s. Colours: Approved colours | Gastro-Resistant |
212 | Lithium Carbonate controlled released Tablets IP 450 mg | Each film coated controlled released tablet contains: Lithium Carbonate IP 450 mg Excipients q.s Colour: Approved Colours | antimanic ( neuro) |
213 | Lithium Carbonate Tablets IP 300 mg | Each uncoated Tablet Contains: Lithium Carbonate IP 300 mg Excipients q.s. | antimanic ( neuro) |
214 | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains: Lornoxicam 4 mg Paracetamol IP 325 mg Excipients q.s. Colours: Approved colours | ANTI INFLAMMATORY |
215 | Losartan Potassium Tablets IP 25 mg | Each film coated tablet contains: Losartan Potassium IP 25 mg Excipients q.s. Colour: Approved colours | Cardiac |
216 | Losartan Potassium Tablets IP 50 mg | Each film coated tablet contains: Losartan Potassium IP 50 mg Excipients q.s. Colour: Approved colours | Cardiac |
217 | Mefenamic Acid & Dicyclomine Hydrochloride Tablets IP | Each uncoated tablet contains: Mefenamic acid IP 250 mg Dicyclomine hydrochloride IP 10 mg Excipients: q.s. Colours: Appproved colours | Neuro |
218 | Mefenamic Acid and Paracetamol Tablets | Each uncoated tablet contains: Mefenamic Acid IP 500 mg Paracetamol IP 325 mg Excipients q.s. | Neuro |
219 | Metformin Hydrochloride ( SR/ER/PR) Voglibose and Glimepiride Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg ( SR/ER/PR) Voglibose IP 0.2 mg Glimepiride IP 1 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
220 | Metformin Hydrochloride ( SR/ER/PR) Voglibose and Glimepiride Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg ( SR/ER/PR) Voglibose IP 0.2 mg Glimepiride IP 2 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
221 | Metformin Hydrochloride ( SR/ER/PR) Voglibose and Glimepiride Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg ( SR/ER/PR) Voglibose IP 0.3 mg Glimepiride IP 1 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
222 | Metformin Hydrochloride ( SR/ER/PR) Voglibose and Glimepiride Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg ( SR/ER/PR) Voglibose IP 0.3 mg Glimepiride IP 2 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
223 | Metformin Hydrochloride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg Voglibose IP 0.2 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
224 | Metformin Hydrochloride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg Voglibose IP 0.3 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
225 | Metformin Hydrochloride Prolonged - release & Glimepiride Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg ( In prolonged release form) Glimepiride IP 0.5 mg Excipients q.s. Colour: Approved colours | Anti-diabetic |
226 | Metformin Hydrochloride Prolonged - release & Glimepiride Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000 mg ( In prolonged release form) Glimepiride IP 1 mg Excipients q.s. Colour: Approved colours | Anti-diabetic |
227 | Metformin Hydrochloride Prolonged - release & Glimepiride Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000 mg ( In prolonged release form) Glimepiride IP 2 mg Excipients q.s. Colour: Approved colours | Anti-diabetic |
228 | Metformin Hydrochloride Prolonged - release & Glimepiride Tablets IP | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg ( In prolonged release form) Glimepiride IP 1 mg Excipients q.s. Colour: Approved colours | Anti-diabetic |
229 | Metformin Hydrochloride Prolonged - release & Glimepiride Tablets IP | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 500 mg ( In prolonged release form) Glimepiride IP 2 mg Excipients q.s. Colour: Approved colours | Anti-diabetic |
230 | Metformin Hydrochloride Prolonged - release Tablets IP 1000 mg | Each film coated prolonged release tablet contains: Metformin Hydrochloride IP 1000 mg Excipients q.s Colours: Approved colour(s) | Anti-diabetic |
231 | Metformin Hydrochloride Prolonged - release Tablets IP 1000 mg | Each uncoated prolonged release tablet contains: Metformin Hydrochloride IP 1000 mg Excipients q.s | Anti-diabetic |
232 | Metformin Hydrochloride prolonged- release Tablets IP 500 mg | Each film coated prolonged- release tablet contains: Metformin Hydrochloride IP 500 mg Excipients q.s Colour: Approved colour(s) | Anti-diabetic |
233 | Metformin Hydrochloride prolonged- release Tablets IP 500 mg | Each uncoated prolonged- release tablet contains: Metformin Hydrochloride IP 500 mg Excipients q.s | Anti-diabetic |
234 | Metformin Hydrochloride Tablets IP 500 mg | Each uncoated tablet contains: Metformin Hydrochloride IP 500 mg Excipients: q.s Colours: Approved colours | Anti-diabetic |
235 | Metformin Hydrochloride Tablets IP 500 mg | Each uncoated tablet contains: Metformin Hydrochloride IP 500 mg Excipients q.s | Anti-diabetic |
236 | Methylcobalamin Tablets 1500 mcg | Each film coated tablet contains: Methylcobalamin IP 1500 mcg Excipients q.s. Colour: Approved colours used | DIETARY SUPPLEMENT |
237 | Methylcobalamin Tablets USP 500 mcg | Each film coated tablet contains: Methylcobalamin USP 500 mcg Excipients q.s. Colour: Approved colours used | neuro |
238 | Methylcobalamin, Alpha Lipoic Acid, Benfothiamine , Pyridoxine HCl, Calcium Pantothenate, Folic Acid, Zinc Oxide, Chrmium Picolinate, Inositol and Lutein Capsules | Each hard gelatin capsule contains: Methylcobalamin IP 1500 mcg Alpha Lipoic Acid USP 100mcg Benfothiamine 15 mg Pyridoxine Hydrochloride IP 3 mg Calcium Pantothenate IP 25 mg Folic Acid IP 1.5 mg Zinc Oxide IP 22.5 mg Chromium Picolinate USP 65 mcg Inositol USP 10 mcg Lutein USP 5 mg Excipients q.s. Approved colours used in hard gelatin capsule shells | DIETARY SUPPLEMENT |
239 | Methylprednisolone Tablets IP | Each uncoated tablet contains: Methylprednisolone IP 4 mg Excipients q.s. | |
240 | Methylprednisolone Tablets IP | Each uncoated tablet contains: Methylprednisolone IP 2 mg Excipients q.s. | ANTI-HISTAMINE |
241 | Methylprednisolone Tablets IP | Each uncoated tablet contains: Methylprednisolone IP 16 mg Excipients q.s. | ANTI-HISTAMINE |
242 | Methylprednisolone Tablets IP | Each uncoated tablet contains: Methylprednisolone IP 8 mg Excipients q.s. | ANTI-HISTAMINE |
243 | Metoprolol Succinate & Amlodipine Besylate Tablets IP | Each film coated extended release tablet contains:Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg Amlodipine Besylate IP Eq. to Amlodipine 2.5 mg Excipients q.s. Colour: Approved colour(s) | Cardiac |
244 | Metoprolol Succinate & Amlodipine Besylate Tablets IP | Each film coated extended release tablet contains:Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. Colour: Approved colour(s) | Cardiac |
245 | Metoprolol Succinate & Amlodipine Besylate Tablets IP | Each film coated extended release tablet contains:Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. Colour: Approved colour(s) | Cardiac |
246 | Metoprolol Succinate extended release Tablets IP 25 mg | Each film coated exended release tablet contains: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg Excipients q.s. Colours: Approved colours | Cardiac |
247 | Metoprolol Succinate extended release Tablets IP 50 mg | Each film coated exended release tablet contains: Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg Excipients q.s. Colours: Approved colours | Cardiac |
248 | Metoprolol Succinate Prolonged Release & Amlodipine Besylate Tablets | Each film coated extended release tablet contains: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As prolonged release) Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. Colour: Approved colour(s) | Cardiac |
249 | Metoprolol Succinate Prolonged Release & Amlodipine Besylate Tablets | Each film coated extended release tablet contains: Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg (As prolonged release) Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. Colour: Approved colour(s) | Cardiac |
250 | Metoprolol Succinate Prolonged Release & Amlodipine Besylate Tablets | Each film coated tablet contains: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As prolonged release) Amlodipine Besylate IP Eq. to Amlodipine 2.5 mg Excipients q.s. Colour: Approved colour(s) | Cardiac |
251 | Metoprolol Succinate Prolonged Release & Amlodipine Besylate Tablets | Each film coated tablet contains: Metoprolol Succinate IP 47.50 mg Eq. to Metoprolol Tartrate 50 mg (As prolonged release) Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. Colour: Approved colour(s) | |
252 | Metoprolol Succinate Prolonged Release & Amlodipine Besylate Tablets | Each film coated tablet contains: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg (As prolonged release) Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. Colour: Approved colour(s) | Cardiac |
253 | Metoprolol Succinate Prolonged Release Tablets IP 25 mg | Each film coatedProlonged -release tablet contains: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg Excipients q.s. Colour: Approved colours | Cardiac |
254 | Metoprolol Succinate Prolonged Release Tablets IP 50 mg | Each film coatedProlonged -release tablet contains: Metoprolol Succinate IP 47.50mg Eq. to Metoprolol Tartrate 50 mg Excipients q.s. Colour: Approved colours | Cardiac |
255 | Metoprolol Succinate ER & Telmisartan Tablets | Each film coated bilayered tablet contains: Metoprolol Succinate IP 23.75 mg Eq. to Metoprolol Tartrate 25 mg ( as extended release) Telmisartan IP 20 mg Excipients q.s. Colours: Approved colours | Cardiac |
256 | Metoprolol Succinate ER & Telmisartan Tablets | Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.5 mg Eq. to Metoprolol Tartrate 50 mg ( as extended release) Telmisartan IP 40 mg Excipients q.s. Colours: Approved colours | Cardiac |
257 | Metoprolol Tartrate Tablets IP 25 mg | Each uncoated tablet contains: Metoprolol Tartrate IP 25 mg Excipients q.s. | Cardiac |
258 | Metoprolol Tartrate Tablets IP 50 mg | Each uncoated tablet contains: Metoprolol Tartrate IP 50 mg Excipients q.s. | Cardiac |
259 | Mirtazapine Orally Disintegrating Tablets USP | Each uncoated orally disintegrating tablet contains: Mirtazapine IP 15 mg Excipients q.s. Colours: Approved colours | atypical antidepressant (neuro) |
260 | Mirtazapine Tablets IP 30 mg | Each film coated tablet contains: Mirtazapine IP 30 mg Excipients q.s Colour: Approved Colours | atypical antidepressant (neuro) |
261 | Mirtazapine Tablets IP | Each film coated tablet contains: Mirtazapine IP 7.5 mg Excipients q.s. Colour: Approved colour(s) | atypical antidepressant (neuro) |
262 | Mirtazapine Tablets IP | Each film coated tablet contains: Mirtazapine IP 15 mg Excipients q.s. Colour: Approved colour(s) | atypical antidepressant (neuro) |
263 | Montelukast and Fexofenadine Hydrochloride tablets | Each film coated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10 mg Fexofenadine Hydrochloride IP 120 mg Excipients q.s. Colour: Approved colour(s) | ANTI-HISTAMINE |
264 | Montelukast and Fexofenadine Hydrochloride Tablets | Each uncoated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10 mg Fexofenadine Hydrochloride IP 120 mg Excipients q.s. | ANTI-HISTAMINE |
265 | Montelukast and Levocetirizine Dihydrochloride Tablets | Each uncoated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10 mg Levocetirizine Dihydrochloride IP 5 mg Excipients q.s. | ANTI-HISTAMINE |
266 | Montelukast sodium and Levocetirizine Dihydrochloride Dispersable Tablets | Each uncoated dispersable tablet contains: Montelukast Sodium IP Eq. to Montelukast 5 mg Levocetirizine Dihydrochloride IP 2.5 mg Excipients q.s. Colour: Approved colours used | ANTI-HISTAMINE |
267 | Montelukast Sodium and Levocetirizine Hydrochloride Tablets IP | Each uncoated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10 mg Levocetirizine Hydrochloride IP 5 mg Excipients q.s. | ANTI-HISTAMINE |
268 | Montelukast Sodium Chewable Tablets 4 mg | Each uncoated chewable tablet contains: Montelukast Sodium IP Eq. to Montelukast 4 mg Excipients q.s. Colours: Approved colour(s) | ANTI-HISTAMINE |
269 | Montelukast Sodium Tablets IP 10 mg | Each uncoated tablet contains: Montelukast Sodium IP Eq. to Montelukast 10 mg Excipients q.s. Colours: Approved colour(s) | ANTI-HISTAMINE |
270 | Naproxen & Domperidone Tablets | Each film coated tablet contains: Naproxen Sodium I.P. 500 mg Domperidone I.P. 10 mg Excipients q.s. Colour: Approved colour(s) | Loan License PP ANTI INFLAMMATORY |
271 | Naproxen & Domperidone Tablets | Each enteric coated tablet contains: Naproxen IP 250 mg Domperidone IP 10 mg Excipients q.s Colour: Approved Colours | ANTI INFLAMMATORY |
272 | Naproxen & Domperidone Tablets | Each enteric coated tablet contains: Naproxen IP 500 mg Domperidone IP 10 mg Excipients q.s Colour: Approved Colours | ANTI INFLAMMATORY |
273 | Naproxen & Domperidone Tablets | Each film coated tablet contains: Naproxen IP 250 mg Domperidone IP 10 mg Excipients q.s. Colour: Approved colour(s) | ANTI INFLAMMATORY |
274 | Naproxen & Domperidone Tablets | Each film coated tablet contains: Naproxen IP 500 mg Domperidone IP 10 mg Excipients q.s. Colour: Approved colour(s) | ANTI INFLAMMATORY |
275 | Naproxen Sodium & Domperidone Tablets | Each film coated tablet contains: Naproxen Sodium USP Eq. to Naproxen 250 mg Domperidone Maleate IP Eq. to Domperidone 10 mg Excipients q.s. Colour: Red oxide of Iron & Titatnium Dioxide IP | ANTI INFLAMMATORY |
276 | Naproxen Sodium & Domperidone Tablets | Each film coated tablet contains: Naproxen Sodium USP Eq. to Naproxen 500 mg Domperidone Maleate IP Eq. to Domperidone 10 mg Excipients q.s. Colour: Approved colour(s) Colour: Red oxide of Iron & Titatnium Dioxide IP | ANTI INFLAMMATORY |
277 | Nimesulide and Paracetamol Tablets | Each uncoated tablet contains: Nimesulide BP 100 mg Paracetamol IP 325 mg Excipients q.s | ANTI INFLAMMATORY |
278 | Nimesulide Tablets | Each uncoated tablet contains: Nimesulide BP 100 mg Excipients q.s | ANTI INFLAMMATORY |
279 | Nitroglycerin Sustained Release Tablets 2.6 mg | Each sustained release tablet contains: Diluted Nitroglycerin IP Eq. to Nitroglycerin 2.6 mg ( In a sustained release form) Excipients q.s. Colour: Approved colour | vasodilators ( Cardiac) |
280 | Ofloxacin and Ornidazole Tablets IP | Each film coated tablet contains: Ofloxacin IP 200 mg Ornidazole IP 500 mg Excipients q.s. Colours: Approved colours | ANTI-BACTERIAL/ANTI-BIOTIC |
281 | Ofloxacin Tablets IP 200 mg | Each film coated tablet contains: Ofloxacin IP 200 mg Excipients q.s. Colours: Approved colours | ANTI-BACTERIAL/ANTI-BIOTIC |
282 | Ofloxacin Tablets IP 200 mg | Each uncoated tablet contains: Ofloxacin IP 200 mg Excipients q.s. | ANTI-BACTERIAL/ANTI-BIOTIC |
283 | Olanzapine & Fluxoetine Tablets IP | Each film coated tablet contains: Olanzapine IP 5 mg Fluoxetine Hydrochloride IP Eq. to Fluoxetine 20 mg Excipients q.s Colour: Approved Colours | atypical antipsychotics +selective serotonin reuptake inhibitors (SSRIs) ( Neuro) |
284 | Olanzapine & Fluxoetine Tablets IP | Each film coated tablet contains: Olanzapine IP 10 mg Fluoxetine Hydrochloride IP Eq. to Fluoxetine 20 mg Colour: Approved Colours | atypical antipsychotics +selective serotonin reuptake inhibitors (SSRIs) ( Neuro) |
285 | Olanzapine mouth dissoloving Tablets 10 mg | Each uncoated mouth dissolving tablet contains: Olanzapine IP 10 mg Excipients q.s Colour: Approved Colours | atypical antipsychotics ( Neuro) |
286 | Olanzapine mouth dissoloving Tablets 15 mg | Each uncoated mouth dissolving tablet contains: Olanzapine IP 15 mg Excipients q.s Colour: Approved Colours | atypical antipsychotics ( Neuro) |
287 | Olanzapine mouth dissoloving Tablets 5mg | Each uncoated mouth dissolving tablet contains: Olanzapine IP 5 mg Excipients q.s Colour: Approved Colours | atypical antipsychotics ( Neuro) |
288 | Olanzapine mouth dissoloving Tablets 7.5 mg | Each uncoated mouth dissolving tablet contains: Olanzapine IP 7.5 mg Excipients q.s Colour: Approved Colours | atypical antipsychotics ( Neuro) |
289 | Olanzapine Tablets IP 10 mg | Each film coated tablet contains: Olanzapine IP10mg Colour: Approved colour | atypical antipsychotics ( Neuro) |
290 | Olanzapine Tablets IP 15 mg | Each film coated tablet contains: Olanzapine IP 15 mg Colour: Approved colour | atypical antipsychotics ( Neuro) |
291 | Olanzapine Tablets IP 2.5 mg | Each film coated tablet contains: Olanzapine IP 2.5 mg Colour: Approved colour | atypical antipsychotics ( Neuro) |
292 | Olanzapine Tablets IP 20 mg | Each film coated tablet contains: Olanzapine IP 20 mg Colour: Approved colour | atypical antipsychotics ( Neuro) |
293 | Olanzapine Tablets IP 5 mg | Each film coated tablet contains: Olanzapine IP 5 mg Colour: Approved colour | atypical antipsychotics ( Neuro) |
294 | Olanzapine Tablets IP 7.5 mg | Each film coated tablet contains: Olanzapine IP 7.5 mg Colour: Approved colour | atypical antipsychotics ( Neuro) |
295 | Omeprazole and Domperidone Capsules IP | Each hard gelatin capsule contains: Omeprazole IP 20 mg ( As enteric coated pellets) Domperidone IP 10 mg ( As coated pellets) Approved colours used in hard gelatin capsule shells | Gastro-Resistant |
296 | Omeprazole and Domperidone Capsules IP | Each hard gelatin capsule contains: Omeprazole IP 10 mg ( As enteric coated pellets) Domperidone Maleate IP 10 mg ( As coated pellets) Colour: Approved colours Approved colours used in hard gelatin capsule shells | Gastro-Resistant |
297 | Omeprazole gastro- resistant Capsules IP | Each hard gelatin capsule contains: Omeprazole IP 20 mg ( As gastro - resistant pellets) Colour: Titanium dioxide IP Excipients: q.s. Approved colours used in hard gelatin capsules shells | Gastro-Resistant |
298 | Omeprazole gastro- resistant Capsules IP | Each hard gelatin capsule contains: Omeprazole IP 20 mg ( As gastro - resistant pellets) Colour: Titanium dioxide IP Excipients: q.s. Approved colours used in empty hard gelatin capsule shells | Loan License PP Gastro-Resistant |
299 | Omperazole & Domperidone Capsules IP | Each hard gelatin capsule contains: Omperazole IP 20 mg ( As Gastro - resistant pellets) Domperidone IP 10 mg ( As coated pellets) Excipients q.s. Approved colours used in hard gelatin capsules shells | Gastro-Resistant |
300 | Omperazole Gastro-resistant Capsules BP | Each hard gelatin capsule contains : Omeprazole BP 20 mg ( As enteric coated pellets) Approved colours used in empty hard gelatin capsule shells | Gastro-Resistant |
301 | Omperazole Gastro-resistant Capsules IP 20 mg | Each hard gelatin capsule contains : Omeprazole IP 20 mg ( As enteric coated pellets) Approved colours used in empty hard gelatin capsule shells | Gastro-Resistant |
302 | Ondansetron Orally Disintegrating Tablets IP | Each uncoated orally disintegrating tablet contains: Ondansetron Hydrochloride IP Eq. to Ondansetron 4 mg Excipients q.s. Colours: Approved colours | Gastro-Resistant |
303 | Orlistat capsules USP 120 mg | Each hard gelatin capsule contains: Orlistat USP 120 mg ( as pellets 50% w/w) Approved colours used in hard gelatin capsule shells | Cardiac /Lipase Inhibitor/ Anti-obesity |
304 | Orlistat capsules USP 60 mg | Each hard gelatin capsule contains: Orlistat USP 60 mg ( as pellets 50% w/w) Approved colours used in hard gelatin capsule shells | Cardiac /Lipase Inhibitor/ Anti-obesity |
305 | Pantoprazole & Domperidone Tablets | Each enteric coated tablet contains: Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 20 mg Domperidone IP 10 mg Excipients q.s Colours: Approved colours | Gastro-Resistant |
306 | Pantoprazole & Domperidone Tablets | Each enteric coated tablet contains: Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg Domperidone IP 10 mg Excipients q.s Colours: Approved colours | Gastro-Resistant |
307 | Pantoprazole Enteric coated and Levosulpiride Sustained Release Capsules | Each hard gelatin capsule contains: Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg (As enteric coated pellets) Levosulpiride 75 mg (As sustained release pellets) Approved colours used in empty capsule shells | Gastro-Resistant |
308 | Pantoprazole Gastro - resistant Tablets IP 40 mg | Each enteric coated tablet contains: Pantoprazole sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg Excipients: q.s. Colours: Yellow oxide of Iron & Titanium IP | Gastro-Resistant |
309 | Pantoprazole Gastro- Resistant & Domperidone Prolonged- Release Capsules IP | Each hard gelatin capsule contains: Pantoprazole Sodium Sesquihydrate IP Eq.to Pantoprazole 40 mg (As enteric coated pellets) Colour: Brilliant Blue FCF Domperidone IP 30 mg (As prolonged release pellets) Colour: Sunset yellow FCF Approved colours used in hard gelatin capsules shells | Gastro-Resistant |
310 | Pantoprazole Gastro-resistant & Domperidone Prolonged - release Capsules IP | Each hard gelatin capsule contains: Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg ( As enteric coated pellets) Colour: Brillient Blue FCF Domperidone IP 30 mg ( As Prolonged release pellets) Colour: Sunset Yellow FCF Approved colours used in empty hard gelatin capsule shells | Gastro-Resistant |
311 | Pantoprazole Gastro-resistant & Domperidone Prolonged - release Capsules IP | Each hard gelatin capsule contains: Pantoprazole Sodium IP Eq. to Pantoprazole 40 mg ( As gastro-resistant pellets) Colour: Brillient Blue FCF Domperidone IP 30 mg ( As Prolonged release pellets) Colour: Sunset Yellow FCF Approved colours used in hard gelatin capsule shells | |
312 | Pantoprazole Gastro-resistant Tablets IP 20 mg | Each enteric coated tablet contains: Pantoprazole sodium Sesquihydrate IP Eq. to Pantoprazole 20 mg Excipients: q.s. Colours: Approved colours | Gastro-Resistant |
313 | Pantoprazole Gastro-resistant Tablets IP 40 mg | Each enteric coated tablet contains: Pantoprazole sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg Excipients: q.s. Colours: Approved colours | Gastro-Resistant |
314 | Pantoprazole Gastro-resistant Tablets IP 40 mg | Each Gastro-resistant tablet contains: Pantoprazole sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg Excipients: q.s. Colours: Approved colours | Gastro-Resistant |
315 | Pntaloc 20 Pantoprazole Gastro-resistant Tablets I.P. 20 mg | Each enteric coated tablet contains: Pantoprazole Soidum Sesquihydrate I.P. equivalent to Pantoprazole 20 mg Excipients q.s. Colour: Red Oxide of Iron | Gastro-Resistant |
316 | Pntaloc 40 Pantoprazole Gastro-resistant Tablets I.P. 40 mg | Each enteric coated tablet contains: Pantoprazole Soidum Sesquihydrate I.P. equivalent to Pantoprazole 40 mg Excipients q.s. Colour: Red Oxide of Iron | Gastro-Resistant |
317 | Pantoprazole Sodium Delayed Release Tablets USP 40 mg | Each enteric coated tablet contains: Pantoprazole Sodium USP Eq. to Pantoprazole 40 mg Excipients q.s. Colours: Approved colours | Gastro-Resistant |
318 | Pantoprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg Domperidone IP 10 mg Colours: Approved colours | Gastro-Resistant |
319 | Paracetamol Cetirizine Hydrochloride and Phenylephrine Hydrochloride Tablets | Each uncoated tablet contains: Paracetamol IP 325 mg Cetirizine Hydrochloride IP 5 mg Phenylephrine Hydrochloride IP 5 mg Excipients q.s. | Analgesics and antipyretics + Antihistamine |
320 | Paracetamol Tablets IP 500 mg | Each uncoated tablet contains: Paracetamol IP 500 mg Excipients q.s. | Analgesics |
321 | Paracetamol Tablets IP 650 mg | Each uncoated tablet contains: Paracetamol IP 650 mg Excipients q.s. | Analgesics |
322 | Paroxetine Prolonged - Release Tablets IP 12.5 mg | Each film coated prolonged release tablet contains: Paroxetine Hydrochloride IP Eq. to Paroxetine 12.5 mg Excipients q.s. Colour: Approved colours | (SSRI) (Neuro) |
323 | Paroxetine Prolonged - Release Tablets IP 25 mg | Each film coated prolonged release tablet contains: Paroxetine Hydrochloride IP Eq. to Paroxetine 25 mg Excipients q.s. Colour: Approved colours | (SSRI) (Neuro) |
324 | Phenytoin Sodium Tablts IP 100 mg | Each film coated Tablet Contains: Phenytoin Sodium IP 100 mg Excipients q.s Colour: Approved Colours | anticonvulsants (Neuro) |
325 | Phenytoin Sodium Tablts IP 50 mg | Each film coated Tablet Contains: Phenytoin Sodium IP 50 mg Excipients q.s Colour: Approved Colours | anticonvulsants (Neuro) |
326 | Piracetam Tablets 400 mg | Each film coated Tablet Contains: Piracetam IP 400 mg Excipients q.s Colour: Approved Colours | Neuro |
327 | Piracetam Tablets 800 mg | Each film coated Tablet Contains: Piracetam IP 800 mg Excipients q.s Colour: Approved Colours | Neuro |
328 | Prazosin Hydrochloride Extended release Tablets | Each film coated exended release tablet contains: Prazosin hydrochloride IP Eq. to Prazosin 5 mg Excipients q.s. Colours: Approved colours | neuro |
329 | Prazosin Hydrochloride Extended release Tablets | Each film coated exended release tablet contains: Prazosin hydrochloride IP Eq. to Prazosin 2.5 mg Excipients q.s. Colours: Approved colours | neuro |
330 | Pregabalin & Methylcobalamin capsules | Each hard gelatin capsule contains: Pregabalin USP 75 mg Methylcobalamin JP 750 mcg Excipients q.s. Colurs:Approved colours used in empty hard gelatin capsule shells | neuro |
331 | Pregabalin & Methylcobalamin capsules | Each hard gelatin capsule contains: Pregabalin 75 mg Methylcobalamin 750 mcg Excipients q.s. Approved colours used in empty hard gelatin capsule shells | neuro |
332 | Pregabalin & Methylcobalamin capsules IP | Each hard gelatin capsule contains: Pregabalin IP 75 mg Methylcobalamin IP 750 mcg Excipients q.s. Approved colours used in empty hard gelatin capsule shells | neuro |
333 | Pregabalin and Methylcobalamin Capsules IP | Each hard gelatin capsule contains: Pregabalin IP 75 mg Methylcobalamin IP 500 mcg Excipients q.s. Approved colours used in empty hard gelatin capsule shell | neuro |
334 | Pregabalin Capsules | Each hard gelatin capsule contains: Pregabalin 75 mg Excipients q.s. Approved colours used in empty hard gelatin capsule shells | neuro |
335 | Pregabalin Capsules IP 75 mg | Each hard gelatin capsule contains: Pregabalin IP 75 mg Approved colours used in empty hard gelatin capsule shells | |
336 | Pregabalin Capsules IP 150 mg | Each hard gelatin capsule contains: Pregabalin IP 150 mg Approved colours used in empty hard Gelatin capsule shell | neuro |
337 | Pregabalin Capsules IP 300 mg | Each hard gelatin capsule contains: Pregabalin IP 300 mg Approved colours used in empty hard Gelatin capsule shell | neuro |
338 | Pregabalin, Methylcobalamn, Benfothiamine, pyridoxine HCl and Folic acid Capsules | Each hard gelatin capsule contains: Pregabalin IP75 mg methylcobalamin IP 750 mcg Benfothiamine 7.5 mg Pyridoxine Hydrochlorie IP 1.5 mg Folic acid IP 0.75 mg Excipients q.s. Approved colour used in hard gelatin capsules shells | neuro |
339 | Proanthocyanidin tablets | Each film coated tablet contains: Proanthocyanidin 75 mg Excipients q.s. Colours: Approved colours | anti-inflammatory |
340 | Propanolol Hydrochloride Tablets IP 10 mg | Each uncoated tablet contains: Propanolol Hydrochloride IP 10 mg | Anti-hypertensive ( Cardiac) |
341 | Propanolol Hydrochloride Tablets IP 20 mg | Each uncoated tablet contains: Propanolol Hydrochloride IP 20 mg | Anti-hypertensive ( Cardiac) |
342 | Propanolol Hydrochloride Tablets IP 40 mg | Each uncoated tablet contains: Propanolol Hydrochloride IP 40 mg | Anti-hypertensive ( Cardiac) |
343 | Propanolol Hydrochloride Tablets USP 40 mg | Each uncoated tablet contains: Propanolol Hydrochloride USP 40 mg Excipients q.s. | Anti-hypertensive ( Cardiac) |
344 | Propranolol Hydrochloride Time release capsules 40 mg | Each timed released capsule contains: Propranolol Hydrochloride IP 40 mg Approved colours used in empty hard Gelatin capsule shell | Anti-hypertensive ( Cardiac) |
345 | Propranolol Hydrochloride Time release capsules 80 mg | Each timed released capsule contains: Propranolol Hydrochloride IP 80 mg Approved colours used in empty hard Gelatin capsule shell | Anti-hypertensive ( Cardiac) |
346 | Quetiapine Extended -Release Tablets USP 50 mg | Each film coated extended - release tablet contains: Quetiapine Fumarate USP Eq. to Quetiapine 50 mg Excipients q.s. Colour: Approved colour used | neuro |
347 | Quetiapine Fumarate Tablets IP 100 mg | Each film coated tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 100 mg Colour: Approved colours | neuro |
348 | Quetiapine Fumarate Tablets IP 200 mg | Each film coated tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 200 mg Colour: Approved colours | neuro |
349 | Quetiapine Fumarate Tablets IP 25 mg | Each film coated extended - release tablet contains: Quetiapine Fumarate USP Eq. to Quetiapine 50 mg Excipients q.s. Colour: Approved colour used | neuro |
350 | Quetiapine Fumarate Tablets IP 300 mg | Each film coated tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 300 mg Colour: Approved colours | neuro |
351 | Quetiapine Fumarate Tablets IP 50 mg | Each film coated tablet contains: Quetiapine Fumarate IP Eq. to Quetiapine 50 mg Colour: Approved colours | neuro |
352 | Quinine Sulphate Tablets USP | Each film coated tablet contains: Quinine Sulphate USP 100 mg Excipients q.s. Colours: Approved colours used | ANTI-MALARIALS |
353 | Rabeprazole ( EC) and Levosupiride ( SR) Capsules | Each hard gelatin capsule contains: Rabeprazole Sodium IP 20mg (As enteric coated pellets) Levosulpiride 75 mg ( As sustained release pellets) Approved colours used in empty capsule shells | Gastro-Resistant |
354 | Rabeprazole ( Ecnteric coated) and Levosupiride ( Sustained Release) Capsules ULCELIX PLUS | Each hard gelatin capsule contains: Rabeprazole Sodium USP 20mg (As enteric coated pellets) Levosulpiride 75 mg ( As sustained release pellets) Colour: Approved colours used in empty capsule shells | Gastro-Resistant |
355 | Rabeprazole and Domperidone Tablets | Each enteric coated tablet contains: Rabeprazole Sodium IP 20 mg Domperidone IP 10 mg Excipients q.s. Colours: Approved colours | Gastro-Resistant |
356 | Rabeprazole EC & Domperidone SR Capsules | Each hard gelatin capsule contains: Rabeprazole Sodium IP 20 mg ( As enteric coated pellets) Domperidone IP 30 mg ( As sustained release pellets) Approved colours used in hard gelatin capsule shells | Gastro-Resistant |
357 | Rabeprazole Gastro-resistant tablets IP | Each gastro-resistant tablet contains: Rabeprazole Sodium IP 20 mg Excipients q.s. Colours: Approved colour(s) | Gastro-Resistant |
358 | Rabeprazole Gastro-resistant tablets IP 20 mg | Each enteric coated tablet contains: Rabeprazole Sodium IP 20 mg Excipients q.s. Colours: Approved colours | Gastro-Resistant |
359 | Rabeprazole Gastro-resistant tablets IP 20 mg | Each enteric coated tablet contains: Rabeprazole Sodium IP 20 mg Excipients q.s. Colours: Red oxide of Iron & Titanium dioxide IP | Gastro-Resistant |
360 | Rabeprazole Gastro-resistant tablets IP 20 mg | Each enteric coated tablet contains: Rabeprazole Sodium IP 20 mg Excipients q.s. Colours: Yellow oxide of Iron & Titanium dioxide IP | Gastro-Resistant |
361 | Rabeprazole Sodium & Dornperidone Capsules | Each hard gelatin capsule contains: Rabeprazole Sodium IP 20mg (As enteric coated pellets) Domperidone Maleate IP Eq. to Domperidone 20mg (As Sustained release pellets) Domperidone Maleate IP Eq. to Domperiaone 10 mg (As immediate release pellets) Approved colours used in empty hard gelatin capsule shell | Gastro-Resistant |
362 | Rabeprazole Sodium & Dornperidone Capsules | Each hard gelatin capsule contains: Rabeprazole Sodium IP 20 mg (A Gastro - resistant pellets) Colour iron oxide red Domperidone IP 30 mg ( As sustained release pellets) Colour: Sunset yellow FCF Excipients q.s. Approved colours used in hard gelatin capsule shells | Gastro-Resistant |
363 | Ramipril Tablets IP 2.5 mg | Each uncoated tablet contains: Ramipril IP 2.5 mg Excipients q.s. | |
364 | Ramipril Tablets IP 5 mg | Each uncoated tablet contains: Ramipril IP 5 mg Excipients q.s. | cardiac |
365 | Risperidone and Trihexyphenidyl Hydrochlorde Tablets | Each film coated tablet contains: Risperidone BP 2 mg Trihexyphenidyl hydrochloride IP 2 mg Excipients q.s. Colours: Approved colours | Neuro ( Neuropathic pain relievers) |
366 | Risperidone Tablets IP | Each film coated Tablet Contains: Risperidone IP 1 mg Excipients q.s Colour: Approved Colours | Neuro |
367 | Risperidone Tablets IP | Each film coated Tablet Contains: Risperidone IP 2 mg Excipients q.s Colour: Approved Colours | Neuro |
368 | Rosuvastatin & Fenofibrate Tablets | Each film coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg Fenofibrate IP 145 mg Excipients q.s. Colours: Approved Colours | cardiac |
369 | Rosuvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg Fenofibrate IP 160 mg Excipients q.s. Colours: Approved Colours | cardiac |
370 | Rosuvastatin Calcium Tablets IP 10 mg | Each film coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg Excipients q.s. Colours: Approved Colours | cardiac care |
371 | Rosuvastatin Calcium Tablets IP 20 mg | Each film coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 20 mg Excipients q.s. Colours: Approved Colours | cardiac care |
372 | Rosuvastatin Calcium Tablets IP 5 mg | Each film coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 5 mg Excipients q.s. Colours: Approved Colours | cardiac care |
373 | Rosuvastatin Tablets IP 10 mg | Each film coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg Excipients q.s. Colours: Approved Colours | cardiac care |
374 | Rosuvastatin Tablets IP 5 mg | Each film coated tablet contains: Rosuvastatin Calcium IP Eq. to Rosuvastatin 5 mg Excipients q.s. Colours: Approved Colours | cardiac care |
375 | Roxithromycin Dispersable Tablets 50 mg | Each uncoated dispersable tablet contains: Roxithromycin IP 50 mg Excipients q.s. Colours: Sunset Yellow FCF | Antibiotic |
376 | Roxithromycin Tablets 150mg | Each film coated tablet contains: Roxithromycin BP 150 mg Excipients q.s. Colours: Approved colours used | Antibiotic |
377 | Serratiopeptidase Tablets IP 10 mg | Each film coated tablet contains: Serratiopeptidase IP 10 mg ( As enteric coated granules equivalent to enzyme activity 20,000 units) Excipients q.s. Colour: Approved Colour(s) | ANTI INFLAMMATORY |
378 | Serratiopeptidase Tablets IP 10 mg | Each film coated tablet contains: Serratiopeptidase IP 10 mg ( As enteric coated 20,000 units) Colour: Approved Colour(s) | ANTI INFLAMMATORY |
379 | Sertraline Hydrochloride Tablets IP 100 mg | Each film coated tablet contains: Sertraline Hydrochloride BP Eq. to Sertraline 100 mg Colours: Approved colours | SSRI (Neuro) |
380 | Sertraline Hydrochloride Tablets IP 25 mg | Each film coated tablet contains: Sertraline Hydrochloride IP Eq. to Sertraline 25 mg Colours: Lake of Quinoline yellow and Brilliant Blue | SSRI (Neuro) |
381 | Sertraline Hydrochloride Tablets IP 50 mg | Each film coated tablet contains: Sertraline Hydrochloride IP Eq. to Sertraline 50 mg Colours: Approved colours | SSRI (Neuro) |
382 | Sertraline Tablets BP | Each film coated tablet contains: Sertraline Hydrochloride BP Eq. to Sertraline 50 mg Excipients q.s. Colours: Approved colours used | SSRI (Neuro) |
383 | Sildenafil Citrate Tablets IP 100 mg | Each film coated tablet contains: Sildenafil Citrate IP Eq. to Sildenafil 100 mg Excipients q.s. Colours: Approved colours | ERECTILE DYSFUNCTION |
384 | Sildenafil Citrate Tablets IP 25 mg | Each film coated tablet contains: Sildenafil Citrate IP Eq. to Sildenafil 25 mg Excipients q.s. Colours: Approved colours | ERECTILE DYSFUNCTION |
385 | Sildenafil Citrate Tablets IP 50 mg | Each film coated tablet contains: Sildenafil Citrate IP Eq. to Sildenafil 50 mg Excipients q.s. Colours: Approved colours | ERECTILE DYSFUNCTION |
386 | Sildenafil Tablets USP 100 mg | Each film coated tablet contains: Sildenafil Citrate USP Eq. to Sildenafil 100 mg Excipients q.s. Colours: Approved colours used | ERECTILE DYSFUNCTION |
387 | Sildenafil Tablets USP 50 mg | Each film coated tablet contains: Sildenafil Citrate USP Eq. to Sildenafil 50 mg Excipients q.s. Colours: Approved colours used | ERECTILE DYSFUNCTION |
388 | Sitagliptin and Dapagliflozin Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP Eq. to Sitagliptin 100 mg Dapagliflozin Propanediol Monohydrate Eq. to Dapagliflozin 10 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
389 | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25 mg Eq. to Sitagliptin 50 mg Metformin Hydrochloride IP 500 mg Excipients q.s. Colours: Approved colour(s) | Anti-diabetic |
390 | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25 mg Eq. to Sitagliptin 50 mg Metformin Hydrochloride IP 850 mg Excipients q.s. Colours: Approved colour(s) | Anti-diabetic |
391 | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25 mg Eq. to Sitagliptin 50 mg Metformin Hydrochloride IP 1000 mg Excipients q.s. Colours: Approved colour(s) | Anti-diabetic |
392 | Sodium Valporate & valporic acid tablets | Each film coated tablet contains: Sodium Valporate IP 200 mg Valporic acid IP 87 mg (Both together corresponds to sodium valporate 300 mg) Colour: Approved Colours | Neuro |
393 | Sodium Valporate Gastro-Resistant tablets | Each enteric Tablet Contains: Sodium Valporate IP 500 mg Excipients q.s Colour: Approved Colours used | Neuro |
394 | Sodium Valporate Gastro-Resistant tablets | Each enteric coated tablet contains: Sodium Valporate IP 300 mg Colour: Approved Colours | Neuro |
395 | Sodium Valproate & Valproic acid controlled release Tablets | Each film coated controlled release tablet contains: Sodium valproate IP 133 mg Valproic acid IP 58 mg ( Both together corresponds to sodium valproate 200 mg) Colour: Approved colours | Neuro |
396 | Sodium Valproate & Valproic acid controlled release Tablets | Each film coated controlled release tablet contains: Sodium valproate IP 333 mg Valproic acid IP 145 mg ( Both together corresponds to sodium valproate 500 mg) Colour: Approved colours | Neuro |
397 | Sodium Valproate & Valproic acid controlled release Tablets | Each film coated controlled release tablet contains: Sodium valproate IP 200 mg Valproic acid IP 87 mg ( Both together corresponds to sodium valproate 300 mg) Colour: Approved colours | Neuro |
398 | Sodium valproate Gastro-Resistant Tablets BP | Each enteric coated tablet contains: Sodium Valproate BP 200 mg Excipients q.s. Colours: Approved colours used | Neuro |
399 | Sodium valproate Prolonged-Resistant Tablets BP 200 mg | Each film coated prolonged release tablet contains: Sodium Valproate BP 200 mg Excipients q.s. Colours: Approved colours used | Neuro |
400 | Sodium valproateGastro-Resistant Tablets IP 200 mg | Each enteric coated tablet contains: Sodium Valproate IP 200 mg Excipients q.s. Colours: Approved colours | Neuro |
401 | Tadalafil Tablets IP 10 mg | Each film coated tablet contains: Tadalafil IP 10 mg Excipients q.s. Colours: Approved colours | ERECTILE DYSFUNCTION |
402 | Tadalafil Tablets IP 20 mg | Each tablet contains: Tadalafil IP 20 mg Excipients q.s. Colours: Approved colours | ERECTILE DYSFUNCTION |
403 | Tadalafil Tablets USP 10 mg | Each tablet contains: Tadalafil USP 10 mg Excipients q.s. Colours: Approved colours used | ERECTILE DYSFUNCTION |
404 | Tadalafil Tablets USP 5 mg | Each tablet contains: Tadalafil USP 5 mg Excipients q.s. Colours: Approved colours used | ERECTILE DYSFUNCTION |
405 | Telmisartan & Almodipine Tablets IP | Each uncoated tablet conatins: Telmisartan IP 40 mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s | Antihypertension ( cardiac) |
406 | Telmisartan & Amlodipine Besylate Tablets IP | Each uncoated tablet contains: Telmisartan IP 80 mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. | Antihypertension ( cardiac) |
407 | Telmisartan & Hydrochlorthiazide Tablets IP | Each uncoated tablet contains: Telmisartan IP 40 mg Hydrochlorthiazide IP 12.5 mg Excipients q.s. Colours: Approved colour | Antihypertension ( cardiac) |
408 | Telmisartan & Hydrochlorthiazide Tablets IP | Each uncoated tablet contains: Telmisartan IP 80 mg Hydrochlorthiazide IP 12.5 mg Excipients q.s. Colours: Approved colour | Antihypertension ( cardiac) |
409 | Telmisartan and Atorvastatin Calcium Tablets | Each film coated tablet contains: Telmisartan IP 40 mg Atorvastatin Calcium IP Equivalent to Atorvastatin 10 mg Colours: Approved colours | Antihypertension ( cardiac) |
410 | Telmisartan and Ramipril Tablets | Each film coated tablets contains: Telmisartan IP 40 mg Ramipril 5 mg Colours: Approved colours | cardiac |
411 | Telmisartan Hydrochlorthiazide & Amlodipine Tablets | Each uncoated tablet contains: Telmisartan IP 40 mg Amlodipine Besylate IP Eq. to Amlodipine 5 mg Hydrochlorthiazide IP 12.5 mg Excipients q.s | cardiac |
412 | Telmisartan Tabets IP 20 mg | Each uncoated tablet contains: Telmisartan IP 20 mg Excipients q.s. | cardiac |
413 | Telmisartan Tabets IP 40 mg | Each uncoated tablet contains: Telmisartan IP 40 mg Excipients q.s. Colours: Approved colour | cardiac |
414 | Telmisartan Tabets IP 40 mg | Each film coated tablet contains: Telmisartan IP 40 mg Excipients q.s. Colours: Approved colour | cardiac |
415 | Telmisartan Tabets IP 40 mg | Each uncoated tablet contains: Telmisartan IP 40 mg Excipients q.s. | cardiac |
416 | Telmisartan Tabets USP 40 mg | Each tablet contains: Telmisartan USP 40 mg Excipients q.s. Colours: Approved colours used | cardiac |
417 | Telmisartan Tablets IP 80 mg | Each uncoated tablet contains: Telmisartan IP 80 mg Excipients q.s. Colours: Approved colours | cardiac |
418 | Teneligliptin Tablets IP 20 mg | Each film coated tablet contains: Teneligliptin Hydrochloride Hydrate IP Eq. to Teneligliptin 20 mg Excipient q.s. Colour: Approved colours | Anti-diabetic |
419 | Teneligliptin & Metformin Hydrochloride (Extended Release) Tablets | Each uncoated bilayered tablet contains: Teneligliptin Hydrochloride Hydrate IP Eq. to Teneligliptin 20 mg Metformin Hydrochloride IP 500 mg ( As Extended Release Form) Excipient q.s. Colour: Approved colours | Anti-diabetic |
420 | Teneligliptin & Metformin Hydrochloride (Extended Release) Tablets | Each uncoated bilayered tablet contains: Teneligliptin Hydrochloride Hydrate IP Eq. to Teneligliptin 20 mg Metformin Hydrochloride IP 1000 mg ( As Extended Release Form) Excipient q.s. Colour: Approved colours | Anti-diabetic |
421 | Teneligliptin & Metformin Hydrochloride Prolonged- Release Tablets | Each uncoated bilayered tablet contains: Teneligliptin Hydrochloride Hydrate IP 20 mg Metformin Hydrochloride IP 500 mg ( As Prolonged- Release Form) Excipient q.s. Colour: Approved colours | Anti-diabetic |
422 | Teneligliptin & Metformin Hydrochloride Prolonged- Release Tablets | Each uncoated bilayered tablet contains: Teneligliptin Hydrochloride Hydrate IP 20 mg Metformin Hydrochloride IP 1000 mg ( AsProlonged- Release Form) Excipient q.s. Colour: Approved colours | |
423 | Teneligliptin 20 mg & Metformin Hydrochloride 500 mgExtended Release Tablets IP | Each uncoated bilayered tablet contains: Teneligliptin Hydrochloride Hydrate IP Eq. to Teneligliptin 20 mg Metformin Hydrochloride IP 500 mg ( As Extended Release Form) Excipient q.s. Colour: Ferric Oxide Yellow USP - NF ( In Teneligliptin Layer) | Anti-diabetic |
424 | Thiocolchicoside and Etoricoxib tablets | Each film coated tablets contains: Thiocolchicoside IP 4 mg Etoricoxib IP 60 mg Colours: Approved colours | Anti-inflammatory |
425 | Ticagrelor Tablets 90 mg | Each film coated tablet contains: Ticagrelor IP 90 mg Excipients q.s. Colours: Approved colour(s) | antiplatelet medications (Cardiac) |
426 | Topiramate Tablets IP 100 mg | Each film coated Tablet Contains: Topiramate IP 100 mg Excipients q.s Colour: Approved colours | anti-epileptic drugs (Neuro) |
427 | Topiramate Tablets IP 25 mg | Each film coated Tablet Contains: Topiramate IP 25 mg Excipients q.s Colour: Red Iron Oxide | anti-epileptic drugs (Neuro) |
428 | Topiramate Tablets IP 50 mg | Each film coated Tablet Contains: Topiramate IP 50 mg Excipients q.s Colour: Ponceau 4R | anti-epileptic drugs (Neuro) |
429 | Torsemide Tablets IP 10 mg | Each uncoated tablet contains: Torsemide IP 10 mg Excipients q.s. | loop diuretics (Cardiac) |
430 | Torsemide Tablets IP 20 mg | Each uncoated tablet contains: Torsemide IP 20 mg Excipients q.s. | loop diuretics (Cardiac) |
431 | Tranexamic Acid and Mefenamic acid Tablets | Each film coated tablet contains: Tranexamic acid IP 500 mg Mefenamic acid IP 250 mg Excipients q.s. Colour: Approved colour(s) | Antifibryolitic + NSAIDs |
432 | Trimetazidine Hydrochloride Modified Release tablets 35 mg | Each film coated tablet contains: Trimetazidine Hydrochloride IP 35mg Excipients q.s. Colours: Approved colour(s) | Cardiac |
433 | Trimetazidine Hydrochloride Modified Release tablets 35 mg | Each film coated modified release tablet contains: Trimetazidine Hydrochloride IP 35mg Excipients q.s. Colours: Approved colour(s) | Cardiac |
434 | Trimetazidine Hydrochloride Modified Release tablets 60 mg | Each film coated tablet contains: Trimetazidine Hydrochloride IP 60 mg Excipients q.s. Colours: Approved colour(s) | Cardiac |
435 | Trimetazidine Hydrochloride Modified Release tablets 60 mg | Each film coated modified release tablet contains: Trimetazidine Hydrochloride IP 60 mg Excipients q.s. Colours: Approved colour(s) | Cardiac |
436 | Ursodeoxycholic Acid Tablets IP 150 mg | Each film coated tablet contains: ursodeoxycholic acid IP 150 mg Excipients q.s. Colours: Approved Colours | Gastro-Resistant |
437 | Ursodeoxycholic Acid Tablets IP 300 mg | Each film coated tablet contains: ursodeoxycholic acid IP 300 mg Excipients q.s. Colours: Approved Colours | Gastro-Resistant |
438 | Venlafaxine Hydrochloride Tablets 150 mg | Each extended release tablet contains: Venlafaxine Hydrochloride IP Eq. to Venlafaxine 150 mg Excipients q.s Colour: Ponceau 4 R | serotonin and norepinephrine reuptake inhibitors (SNRI) (Neuro) |
439 | Venlafaxine Hydrochloride Tablets IP 37.5 mg | Each extended release tablet contains: Venlafaxine Hydrochloride IP Eq. to Venlafaxine 37.5 mg Excipients q.s Colour: Approved Colours | serotonin and norepinephrine reuptake inhibitors (SNRI) (Neuro) |
440 | Venlafaxine Hydrochloride Tablets IP 75 mg | Each extended release tablet contains: Venlafaxine Hydrochloride IP Eq. to Venlafaxine 75 mg Excipients q.s Colour: Erythrosine | serotonin and norepinephrine reuptake inhibitors (SNRI) (Neuro) |
441 | Prolonged- Release Venlafaxine Tablets P 75 mg | Each Prolonged release tablet contains: Venlafaxine Hydrochloride BP Equivalent to Venlafaxine 75 mg Excipients q.s. Colour: Approved colour(s) used | serotonin and norepinephrine reuptake inhibitors (SNRI) (Neuro) |
442 | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Vildagliptin 50 mg Metformin Hydrochloride IP 500 mg Excipients q.s. Colours: Approved colour(s) | Anti-diabetic |
443 | Vildagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Vildagliptin 50 mg Metformin Hydrochloride IP 1000 mg Excipients q.s. Colours: Approved colour(s) | Anti-diabetic |
444 | Vildagliptin Tablets 100 mg | Each uncoated tablet contains: Vildagliptin IP 100 mg Excipients q.s. | Anti-diabetic |
445 | Vildagliptin Tablets 50 mg | Each uncoated tablet contains: Vildagliptin IP 50 mg Excipients q.s. | Anti-diabetic |
446 | Vildagliptin Tablets IP 100 mg | Each film coated tablet contains: Vildagliptin IP 100 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
447 | Vildagliptin Tablets IP 50 mg | Each film coated tablet contains: Vildagliptin IP 50 mg Excipients q.s. Colours: Approved colours | Anti-diabetic |
448 | Voglibose Tablets IP 0.3 mg | Each uncoated tablet contains: Voglibose IP 0.3 mg Excipients q.s. | Anti-diabetic |
449 | Voglibose Mouth Dissolving Tablets 0.2 mg | Each uncoated mouth dissolving tablet contains: Voglibose IP 0.2 mg Excipients q.s. Colour: Approved colours | Anti-diabetic |
450 | Voglibose Mouth Dissolving Tablets 0.3 mg | Each uncoated mouth dissolving tablet contains: Voglibose IP 0.3 mg Excipients q.s. Colour: Approved colours | Anti-diabetic |
451 | Voglibose Tablets IP 0.2 mg | Each uncoated tablet contains: Voglibose IP 0.2 mg Excipients q.s. Colour: Approved colours | Anti-diabetic |
452 | Voriconazole Tablets IP 200 mg | Each film coaed tablet contains: Voriconazole IP 200 mg Excipients q.s. Colour: Titanium Dioxide IP | Antifungal |
453 | Vortioxetine Hydrobromide Tablets 10 mg | Each film coated tablet contains: Vortioxetine Hydrobromide Eq. to Vortioxetine 10 mg Excipients q.s. Colour: Approved colours | Serotonin Modulator ( neuro) |
454 | Zinc and Vitamin C Chewable Tablets | Each chewable tablet contains: Zinc gluconate 87.1 mg Eq. to elemental Zinc 12.5 mg Ascorbic Acid IP 100 mg Excipients q.s. Colour: Approved colour(s) | DIETARY SUPPLEMENT |